<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2472431863178814657</id><updated>2012-01-29T20:22:44.839+05:30</updated><category term='Turbid Cerebrospinal fluid'/><category term='Characterization'/><category term='DNA shuffling'/><category term='Acute Bacterial Meningitis'/><category term='pyogenic meningitis'/><category term='HIV'/><category term='patients'/><category term='Streptomyces spp.'/><category term='Cloningm cry3'/><category term='OPTIMIZATION OF RAPD-PCR FOR GENETIC'/><category term='STUDY OF GENETIC POLYMORPHISMS AMONG STAPHYLOCOCCUS AUREUS RESPONDING VARIOUSLY TOWARDS VANCOMYCIN'/><category term='Pleocytosis'/><category term='sodium azide'/><category term='hyperrecombination'/><category term='Enhanced Antibacterial Activity of Sodium Azide Treated Mutant Streptomyces Strain'/><category term='Nepal'/><category term='indicator'/><category term='TUTH'/><category term='glucose isomerase'/><category term='Immuno Cross-reactivity'/><category term='GOF'/><category term='Lactose assimilating yeasts'/><category term='Mount Everest Region'/><category term='Nepalese Murcha (Yeast cake)'/><category term='LOF'/><category term='Delta-endotoxin'/><category term='Bacillus thuringiensis'/><category term='FINGERPRINTING'/><category term='mutation'/><category term='cold tolerant Streptomyces species'/><category term='Escherichia coli'/><category term='Thermostable'/><category term='bacterial growth'/><category term='vaccine'/><title type='text'>Kiran Babu Tiwari</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://kiranbabutiwari.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default?start-index=101&amp;max-results=100'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>209</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-1415067753256988192</id><published>2012-01-29T20:15:00.003+05:30</published><updated>2012-01-29T20:22:44.850+05:30</updated><title type='text'>Childish Middle Age</title><content type='html'>Its been feeling childish moments at this middle age. Readings, readings and readings...... Home works, homeworks and homeworks....... Assignments, assignments and assignments......... Unlimited.......&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-1415067753256988192?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1415067753256988192'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1415067753256988192'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2012/01/childish-middle-age.html' title='Childish Middle Age'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-7284761210891972603</id><published>2012-01-11T03:26:00.002+05:30</published><updated>2012-01-11T03:26:49.246+05:30</updated><title type='text'>Construction of Listeria monocytogenes ΔtatAC</title><content type='html'>&lt;a href="http://1.bp.blogspot.com/-9K_OPNINi_U/Twy0GrC8MqI/AAAAAAAAATA/oLSNypCCM1Y/s1600/Untitled.jpg"&gt;&lt;img style="margin: 0px 10px 10px 0px; width: 320px; height: 249px; float: left; cursor: pointer;" id="BLOGGER_PHOTO_ID_5696125655444107938" border="0" alt="" src="http://1.bp.blogspot.com/-9K_OPNINi_U/Twy0GrC8MqI/AAAAAAAAATA/oLSNypCCM1Y/s320/Untitled.jpg" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-7284761210891972603?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/7284761210891972603'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/7284761210891972603'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2012/01/construction-of-listeria-monocytogenes.html' title='Construction of Listeria monocytogenes ΔtatAC'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/-9K_OPNINi_U/Twy0GrC8MqI/AAAAAAAAATA/oLSNypCCM1Y/s72-c/Untitled.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-2138998966316165</id><published>2011-11-19T10:13:00.004+05:30</published><updated>2011-11-20T06:45:55.865+05:30</updated><title type='text'>सबैको भलो होस</title><content type='html'>&lt;div&gt;&lt;div&gt;पहिले पहिले को कुरा , अहिले आएर असान्दर्भिक लाग्न थाल्यो | यो आफ्नो पढाईको साथ साथै ब्यक्तिगत स्वाभाब मा पाएको छु | ती दिन हरु - बीचरा । आफै लाई आफु घाटदै गएको महसुस भएको कुरा सामान्य हुँदै थियो । सम्योग भनु य बध्यता , समय ले रेखा कोर्दो रहेछ । पाइला चाल्नु नयापन भयो, र यो जारी रहने छ । कहिले समय भन्दा अघी भयो, कहिले पछी । तर, यो युयुत्सु अबिरल अबिराम लग्ने छु । रोकिएको थियो बाटो, अब फोहर सफा गर्दै हिंड्नु छ । अरुको कुरा गरेर बिताएको दिन हरु फिर्ता त हुँदैनन्, तर आउने दिन हरुमा आफ्नो कुरा बनाउने परिकल्पना सजाएको छु । सबैको सहयोग (असहयोग्) प्रती म आभारी रहने नै छु । परिवार बाट टाढा हुनु निस्चय नै नरमाइलो महसुश भएको छ । यो पनि जिन्दगी कै अर्को सङ्हर्शा जस्तै भयो । पलायन हुनु पनि युद्द कै अर्को भाग रहेछ । यहाँ पनि त्यस्ता प्रबृत्ती नभएको  भने होईन, तर यहाँ सिस्टम भित्र सबै को पहिचान छ । संसार को यथार्थ - समय छोटो छ, र संसार आफै सानो छ । त्यसैले, सबैलाई सबैको कुरा थाहा हुन्छ । कम्तिमा पनि यो मेरो सन्तोस को श्वास हो । हत्यारा, घुस्याहा र बेइमान बाहेक सबैको भलो होस । &lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-2138998966316165?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2138998966316165'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2138998966316165'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/11/blog-post.html' title='सबैको भलो होस'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-6309019932853645215</id><published>2011-11-16T04:43:00.004+05:30</published><updated>2011-11-16T05:06:50.445+05:30</updated><title type='text'>Generation of tatAC-prom-pAZ106 vector</title><content type='html'>&lt;div&gt;&lt;div align="justify"&gt;&lt;strong&gt;Generation of tatAC-prom-pAZ106 vector&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;1.     Revival of Listeria monocytogenes and its fur-mutants&lt;br /&gt;2.     Grew the bacteria in iron containing and non-iron containing defined media for each strains&lt;br /&gt;3.     Extraction to total RNAs from broth cultures for each&lt;br /&gt;4.     Performed Real-Time PCR with tatA, tatC, lmo (per) and 16S rRNA genes (Negative result for the first time)&lt;br /&gt;5.     Showed down-regulation of tatAC genes in presence of iron&lt;br /&gt;6.     Genomic DNA extraction from the bacteria&lt;br /&gt;7.     Done PCR (first time - negative result)&lt;br /&gt;8.     Done PCR (second time – extremely faint band observed)&lt;br /&gt;9.     Third PCR (band intensity was increased with higher template concentration, but negative control was with the band)&lt;br /&gt;10.   Fourth PCR (changed the polymerase from Phusion to Taq, but same result)&lt;br /&gt;11.    Fifth PCR (changed Taq polymerase, but with the same result)&lt;br /&gt;12.    Sixth PCR (used purchased master mix, but with the same result)&lt;br /&gt;13.   Seventh PCR (used freshly diluted primers, but with the same result)&lt;br /&gt;14.   Designed new primers for different sized (from 123 bp to 500 bp) and different restriction enzymes (from HindIII/EcoRI to BamHI/EcoRI, later ones have compatible buffers) template&lt;br /&gt;15.    Eighth PCR (GOOD RESULT!!!)&lt;br /&gt;16.   Ninth PCR (used for next step)&lt;br /&gt;17.   Restriction digestion with BamHI/EcoRI&lt;br /&gt;18.  Purification of the digested products&lt;br /&gt;19.  Ligated into pGEM-T vector&lt;br /&gt;20. Transformation of E. coli TOP10&lt;br /&gt;21.  Selection of recombinant clone in CIX selective agar&lt;br /&gt;22.  Extraction of plasmid (quantitation, about 1 ng/ul)&lt;br /&gt;23.  Repeated extraction from broth culture with 100 ug/ml carbenicillin rather than 50 ug/ml (similar yield)&lt;br /&gt;24.  Purchased new extraction kit and plasmid extraction (good yield and purity)&lt;br /&gt;25.  Restriction digestion (good result)&lt;br /&gt;26.  Run agarose gel with large quantity&lt;br /&gt;27.  Extraction and purification of the digested tatAC-prom from the gel&lt;br /&gt;28.  Revived E. coli pAZ106 culture&lt;br /&gt;29.  Cultured in broth for mass growth&lt;br /&gt;30.  Extraction of plasmid (pAZ106)&lt;br /&gt;31.  Digestion of the plasmid with BamHI/EcoRI&lt;br /&gt;32.  Purification of the digested plasmid&lt;br /&gt;33.  Ligation of tatAC-prom and pAZ106 vector&lt;br /&gt;34.  Transformation of E. coli TOP10&lt;br /&gt;35.  Selection of recombinant clone in AE selective agar&lt;br /&gt;36.  Selected one out of nine (by individual colony PCRs) clone that might contain tatAC-prom-pAZ106 vector&lt;br /&gt;37.  Extracted plasmids from broth culture of the clone&lt;br /&gt;38.  Restriction digestion of the plasmid (no result)&lt;br /&gt;39.  Repeated digestion with higher concentration of plasmid (GOT THE EXPECTED RESULT!!!)&lt;br /&gt;40.  Recommendation: Transformation of listeria&lt;br /&gt;&lt;br /&gt;Note:&lt;br /&gt;The promoter was aimed to insert in a shuttle vector (pAZ106) so as to amplify in E. coli and characterized and then expressed in Listeria monocytogenes. Therefore, the restriction sites should have been inserted into the PCR products. The PCR products had an “A” overhang at the 3’ ends, that cannot be cloned into the shuttle vector. Neither, the restriction enzymes were able to digest unmethylated DNAs. So, ATGC residues were also inserted on the PCR products along with restriction sites. Then, pGEM-T linear vector was used for TA – Cloning. The recombinant vector must have been defined after transformation. Then the promoter was excised out from the pGEM-T vector and ligated into pAZ106 vector. The last construct was also defined successfully (see figure).&lt;/div&gt;&lt;div&gt; &lt;/div&gt;&lt;div&gt; &lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/-jfCQzY7EtBw/TsL2mfFNVFI/AAAAAAAAAS0/fUcaeTTmDjU/s1600/1.jpg"&gt;&lt;img style="margin: 0px 10px 10px 0px; width: 202px; height: 320px; float: left; cursor: pointer;" id="BLOGGER_PHOTO_ID_5675369621479052370" alt="" src="http://3.bp.blogspot.com/-jfCQzY7EtBw/TsL2mfFNVFI/AAAAAAAAAS0/fUcaeTTmDjU/s320/1.jpg" border="0" /&gt;&lt;/a&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-6309019932853645215?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6309019932853645215'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6309019932853645215'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/11/generation-of-tatac-prom-paz106-vector.html' title='Generation of tatAC-prom-pAZ106 vector'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/-jfCQzY7EtBw/TsL2mfFNVFI/AAAAAAAAAS0/fUcaeTTmDjU/s72-c/1.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-8953673633813607880</id><published>2011-10-28T05:24:00.001+05:30</published><updated>2011-10-28T05:26:18.539+05:30</updated><title type='text'>Standard!!!</title><content type='html'>TU ma fail vayera hideko, yaha ko exam ma ta 97.5% aayo. Khattamai rahe6 ni yahako standard ta. Ke garne, je vayo vayo aba................!!!&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-8953673633813607880?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/8953673633813607880'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/8953673633813607880'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/10/standard.html' title='Standard!!!'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-3271225910403040538</id><published>2011-09-30T07:58:00.006+05:30</published><updated>2011-09-30T08:03:09.665+05:30</updated><title type='text'>Ya, got it.......</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/-Ug4gO_nx2J4/ToUpoBxDowI/AAAAAAAAAR8/lhmzSKuf07I/s1600/4.1.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px; height: 315px;" src="http://3.bp.blogspot.com/-Ug4gO_nx2J4/ToUpoBxDowI/AAAAAAAAAR8/lhmzSKuf07I/s320/4.1.jpg" alt="" id="BLOGGER_PHOTO_ID_5657974274506597122" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/-H7vkf_O74O0/ToUpijpO41I/AAAAAAAAAR0/_TaKqAv9M4A/s1600/5.1.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px; height: 250px;" src="http://4.bp.blogspot.com/-H7vkf_O74O0/ToUpijpO41I/AAAAAAAAAR0/_TaKqAv9M4A/s320/5.1.jpg" alt="" id="BLOGGER_PHOTO_ID_5657974180521370450" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/-My_htURp2xc/ToUpc0PFF4I/AAAAAAAAARs/4qLKRbj9odc/s1600/7.2.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px; height: 253px;" src="http://4.bp.blogspot.com/-My_htURp2xc/ToUpc0PFF4I/AAAAAAAAARs/4qLKRbj9odc/s320/7.2.jpg" alt="" id="BLOGGER_PHOTO_ID_5657974081895864194" border="0" /&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-3271225910403040538?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3271225910403040538'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3271225910403040538'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/ya-got-it.html' title='Ya, got it.......'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/-Ug4gO_nx2J4/ToUpoBxDowI/AAAAAAAAAR8/lhmzSKuf07I/s72-c/4.1.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-5769770102540155764</id><published>2011-09-26T17:17:00.004+05:30</published><updated>2011-09-26T17:25:55.810+05:30</updated><title type='text'>Still, I have half answer</title><content type='html'>&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Table Normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-parent:"";  mso-padding-alt:0in 5.4pt 0in 5.4pt;  mso-para-margin-top:0in;  mso-para-margin-right:0in;  mso-para-margin-bottom:10.0pt;  mso-para-margin-left:0in;  line-height:115%;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; text-align:justify;line-height:normal"&gt;&lt;span style=" font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;mso-fareast-Times New Roman&amp;quot;font-family:&amp;quot;;font-size:12.0pt;"  &gt;Found the identity of the protein from this putative DNA sequence. Had to roll a lot of stones to find it. Still, I could not find why the professor is doing LR-Recombination and generation of transgenic plant with this gene. I suspect that the homologous genes have role in salt tolerance, but, I am not sure. I had submitted the assignment and let's see what turn it will take.&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto; text-align:justify;line-height:normal"&gt;&lt;span style=" font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;mso-fareast-Times New Roman&amp;quot;font-family:&amp;quot;;font-size:12.0pt;"  &gt;ATGGAGAGATCTCAACGGCAGTCTCCTCCGCCACCGTCGCCGTCCTCCTCCTCGTCCTCCGTCTCCGCGGACACCGTCCTCGTCCCTCCCGGAAAGAGGCGGAGGGCGGCGACGGCCAAGGCCGGCGCCGAGCCTAATAAGAGGATCCGCAAGGACCCCGCCGCCGCCGCCGCGGGGAAGAGGAGCTCCGTCTACAGGGGAGTCACCAGGCACAGGTGGACGGGCAGGTTCGAGGCGCATCTCTGGGACAAGCACTGCCTCGCCGCGCTCCACAACAAGAAGAAAGGCAGGCAAGTCTACCTGGGGGCGTATGACAGCGAGGAGGCAGCTGCTCGTGCCTATGACCTCGCAGCTCTCAAGTACTGGGGTCCTGAGACTCTGCTCAACTTCCCTGTGGAGGATTACTCCAGCGAGATGCCGGAGATGGAGGCCGTGTCCCGGGAGGAGTACCTGGCCTCCCTCCGCCGCAGGAGCAGCGGCTTCTCCAGGGGCGTCTCCAAGTACAGAGGCGTCGCCAGGCATCACCACAACGGGAGGTGGGAGGCACGGATTGGGCGAGTCTTTGGGAACAAGTACCTCTACTTGGGAACATTTGACACTCAAGAAGAGGCAGCCAAGGCCTATGACCTTGCGGCCATTGAATACCGTGGCGTCAATGCTGTAACCAACTTCGACATCAGCTGCTACCTGGACCACCCGCTGTTCCTGGCACAGCTCCAACAGGAGCCACAGGTGGTGCCGGCACTCAACCAAGAACCTCAACCTGATCAGAGCGAAACCGGAACTACAGAGCAAGAGCCGGAGTCAAGCGAAGCCAAGACACCGGATGGCAGTGCAGAACCCGATGAGAACGCGGTGCCTGACGACACCGCGGAGCCCCTCACCACAGTCGACGACAGCATCGAAGAGGGCTTGTGGAGCCCTTGCATGGATTACGAGCTAGACACCATGTCGAGACCAAACTTTGGCAGCTCAATCAATCTGAGCGAGTGGTTCGCTGACGCAGACTTCGACTGCAACATCGGATGCCTGTTCGATGGGTGTTCTGCGGCTGACGAAGGAAGCAAGGATGGTGTAGGTCTGGCAGATTTCAGTCTGTTTGAGGCAGGTGATGTCCAGCTGAAGGATGTTCTTTCGGATATGGAAGAGGGGATACAACCTCCAGCGATGATCAGTGTGTGCAACTAA&lt;/span&gt;&lt;span style="Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;font-family:&amp;quot;;font-size:12.0pt;"  &gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-5769770102540155764?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/5769770102540155764'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/5769770102540155764'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/still-i-have-half-answer.html' title='Still, I have half answer'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-5315563276700772851</id><published>2011-09-22T04:29:00.006+05:30</published><updated>2011-09-22T04:58:35.198+05:30</updated><title type='text'>Sequencing SPR1 gene</title><content type='html'>&lt;div  style="text-align: justify; font-family:times new roman;"&gt;&lt;span style="font-size:100%;"&gt;The SPR1 gene was taken by digesting SPR1bBluescript plasmid and replaced to T7-Luciferase plasmid in the position of the enzyme (mentioned). The gene was amplified by specific PCR using SPR1BAMF1 and SPR1SACSTOPR1 primers, digested with BamH1 and Sac1, purified and ligated into BamH1/Sac1 digested T7-Luc plasmid. The purified recombinant vector was amplified in Highly competent E. coli NEB 5-alpha cells. The purified plasmid from the cells were used as template for sequencing reaction using 3.2 pmol/microliter T7 promoter primer and 5 pmol/microliter SPR1SACSTOPR1primer in separate reactions to get two (forward and reverse sequencing) results to compare.&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/-Rxa6EFtRkSQ/TnpvTkZ1YMI/AAAAAAAAARk/azawVUrVxlo/s1600/Untitled.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px; height: 180px;" src="http://4.bp.blogspot.com/-Rxa6EFtRkSQ/TnpvTkZ1YMI/AAAAAAAAARk/azawVUrVxlo/s320/Untitled.jpg" alt="" id="BLOGGER_PHOTO_ID_5654954664097308866" border="0" /&gt;&lt;/a&gt;&lt;/span&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Table Normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-parent:"";  mso-padding-alt:0in 5.4pt 0in 5.4pt;  mso-para-margin-top:0in;  mso-para-margin-right:0in;  mso-para-margin-bottom:10.0pt;  mso-para-margin-left:0in;  line-height:115%;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Table Normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-parent:"";  mso-padding-alt:0in 5.4pt 0in 5.4pt;  mso-para-margin-top:0in;  mso-para-margin-right:0in;  mso-para-margin-bottom:10.0pt;  mso-para-margin-left:0in;  line-height:115%;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Group5 T7 9-20-11.ab1 interpretation:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Sequence obtained:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;NNNNNNNNNNNNNNNNNNNNNNNNN AGGGCCC&lt;span style="background:yellow;mso-highlight:yellow"&gt;GGATCC&lt;/span&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;ATG&lt;/b&gt;GGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCTNNNNNNNNNNTCTCTTTGGTGGTGACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAACGGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCTGTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAACTATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAAGTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAG&lt;b style="mso-bidi-font-weight:normal"&gt;TAA&lt;/b&gt;&lt;span style="background:yellow; mso-highlight:yellow"&gt;GAGCTC&lt;/span&gt;CCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACCGAATTGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCTTGNGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCNAATGCAGGAGTCGCATANNNANAGCGTCNAATGNNCACTCTCAGTACNNNCTGCTCTGANGCCGCATANTNNCCANNCCNNNNNCCNNNNNCCNNTNACGCGCCNGANGGNNTGNNNGNNNNNATCNNTNNNANNANNTNNNNNNNGNNNNNNNNTGCATGNNNNNNGTTNNCNNNNNNCNNNNNNNNNNNNNNNNNNNNNNNTNNGNNNNNCNNNNNANNNNNNNNNNNAN&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Sequence Analysis using FinchTV image:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;First 25 Ntds are not assigned by the sequencer = Ntds in T7 Luc Backbone vector&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;BamH1 restriction site from 33 – 38 Ntds&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;SPR1 gene starts from 39&lt;sup&gt;th&lt;/sup&gt; Ntd&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Ntds from 75 – 85: No Ntd was assigned.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Based on the peaks, the Ntds may be CATTGGATTA&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoListParagraph" style="margin-bottom:0in;margin-bottom:.0001pt; mso-add-space:auto;line-height:normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;The sequence exactly matches in the known SPR1 gene sequence (highlighted)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCT&lt;span style="background:yellow;mso-highlight:yellow"&gt;CATTGGATTA&lt;/span&gt;TCTCTTTGGTGGTGACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAACGGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCTGTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAACTATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAAGTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Poly A residues were observed from 407 – 436&lt;sup&gt;th&lt;/sup&gt; positions with short height peaks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Just before the polyA residues, stop sequence (TAA, 396-398th) and SacI restriction site (399 – 404&lt;sup&gt;th&lt;/sup&gt;) was found.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;Rest of the Ntds must be from vector backbone.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;The “Noise” increased after polyA sequence. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;The height of the peaks seemed to be vague after 541th Ntd.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12pt;"&gt;After 681th Ntd, the sequence identification was largely inconclusive limiting the size (length) of the sequence. (Actually, the sequencer can sequence good to around 800 Ntds. The lower value might be due to contamination during plasmid preparation. This indication was also observed on the gel electrophoresis result of the digested recombinant construct.)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;!--[if !mso]&gt; &lt;style&gt; v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} &lt;/style&gt; &lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves&gt;false&lt;/w:TrackMoves&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable  {mso-style-name:"Table Normal";  mso-tstyle-rowband-size:0;  mso-tstyle-colband-size:0;  mso-style-noshow:yes;  mso-style-priority:99;  mso-style-parent:"";  mso-padding-alt:0in 5.4pt 0in 5.4pt;  mso-para-margin-top:0in;  mso-para-margin-right:0in;  mso-para-margin-bottom:10.0pt;  mso-para-margin-left:0in;  line-height:115%;  mso-pagination:widow-orphan;  font-size:11.0pt;  font-family:"Calibri","sans-serif";  mso-ascii-font-family:Calibri;  mso-ascii-theme-font:minor-latin;  mso-hansi-font-family:Calibri;  mso-hansi-theme-font:minor-latin;  mso-bidi-font-family:"Times New Roman";  mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;97% similarities of the sequenced SPR1 gene were observed for all three entries in the NCBI Blasting as: Identifying the unknown Ntds (as n in the query sequence) will completely match the sequences. Therefore, the sequenced result was good.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&amp;gt;&lt;input name="getSeqGi" value="238479166" type="checkbox"&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/nucleotide/238479166?report=genbank&amp;amp;log$=nuclalign&amp;amp;blast_rank=1&amp;amp;RID=7M4JGPM4011" title="Show report for NM_001161019"&gt;&lt;span style="font-size:10.0pt;font-family: &amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;color:blue"&gt;ref|NM_001161019.1|&lt;/span&gt;&lt;/a&gt;&lt;a name="238479166"&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide&amp;amp;cmd=Display&amp;amp;dopt=nucleotide_unigene&amp;amp;from_uid=238479166&amp;amp;RID=7M4JGPM4011&amp;amp;log$=unigenealign&amp;amp;blast_rank=1"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" alt="Description: UniGene info linked to NM_001161019.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/geoprofiles/?term=238479166%5bgi%5d&amp;amp;RID=7M4JGPM4011&amp;amp;log$=geoalign&amp;amp;blast_rank=1"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" alt="Description: GEO profiles info linked to NM_001161019.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;amp;cmd=search&amp;amp;term=238479166%5bNUID%5d&amp;amp;RID=7M4JGPM4011&amp;amp;log$=genealign&amp;amp;blast_rank=1"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.gif" alt="Description: Gene info linked to NM_001161019.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?direct=on&amp;amp;gbgi=238479166&amp;amp;THE_BLAST_RID=7M4JGPM4011&amp;amp;log$=mapalign&amp;amp;blast_rank=1"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" alt="Description: Genome view with mapviewer linked to NM_001161019.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Arabidopsis thaliana spiral1 (SPR1) mRNA, complete cds&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Length=854&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;amp;cmd=search&amp;amp;term=814896&amp;amp;RID=7M4JGPM4011&amp;amp;log$=geneexplicitnucl&amp;amp;blast_rank=1"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue"&gt;GENE ID: 814896 SPR1&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt; font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; | spiral1 [Arabidopsis thaliana]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;(10 or fewer PubMed links)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Score =&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;628 bits (340),&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Expect = 2e-178&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Identities = 350/360 (97%), Gaps = 0/360 (0%)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Strand=Plus/Plus&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;14&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCT&lt;span style="color:gray"&gt;nnnnnnnnnn&lt;/span&gt;TCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;|||||||||||||||||||||||||||||||||||||&lt;span style="mso-spacerun:yes"&gt;          &lt;/span&gt;|||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;290&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCTCATTGGATTATCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;349&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;74&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;350&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;409&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;134&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;193&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;410&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;469&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;194&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;470&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;529&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;254&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;530&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;589&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;314&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;590&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;649&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&amp;gt;&lt;input name="getSeqGi" value="145359877" type="checkbox"&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/nucleotide/145359877?report=genbank&amp;amp;log$=nuclalign&amp;amp;blast_rank=2&amp;amp;RID=7M4JGPM4011" title="Show report for NM_126416"&gt;&lt;span style="font-size:10.0pt;font-family: &amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;color:blue"&gt;ref|NM_126416.2|&lt;/span&gt;&lt;/a&gt;&lt;a name="145359877"&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide&amp;amp;cmd=Display&amp;amp;dopt=nucleotide_unigene&amp;amp;from_uid=145359877&amp;amp;RID=7M4JGPM4011&amp;amp;log$=unigenealign&amp;amp;blast_rank=2"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" alt="Description: UniGene info linked to NM_126416.2" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/geoprofiles/?term=145359877%5bgi%5d&amp;amp;RID=7M4JGPM4011&amp;amp;log$=geoalign&amp;amp;blast_rank=2"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" alt="Description: GEO profiles info linked to NM_126416.2" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;amp;cmd=search&amp;amp;term=145359877%5bNUID%5d&amp;amp;RID=7M4JGPM4011&amp;amp;log$=genealign&amp;amp;blast_rank=2"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.gif" alt="Description: Gene info linked to NM_126416.2" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?direct=on&amp;amp;gbgi=145359877&amp;amp;THE_BLAST_RID=7M4JGPM4011&amp;amp;log$=mapalign&amp;amp;blast_rank=2"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" alt="Description: Genome view with mapviewer linked to NM_126416.2" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Arabidopsis thaliana spiral1 (SPR1) mRNA, complete cds&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Length=659&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;amp;cmd=search&amp;amp;term=814896&amp;amp;RID=7M4JGPM4011&amp;amp;log$=geneexplicitnucl&amp;amp;blast_rank=2"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue"&gt;GENE ID: 814896 SPR1&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt; font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; | spiral1 [Arabidopsis thaliana]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;(10 or fewer PubMed links)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Score =&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;628 bits (340),&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Expect = 2e-178&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Identities = 350/360 (97%), Gaps = 0/360 (0%)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Strand=Plus/Plus&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;14&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCT&lt;span style="color:gray"&gt;nnnnnnnnnn&lt;/span&gt;TCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;|||||||||||||||||||||||||||||||||||||&lt;span style="mso-spacerun:yes"&gt;          &lt;/span&gt;|||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;95&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCTCATTGGATTATCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;154&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;74&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;155&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;214&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;134&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;193&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;215&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;274&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;194&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;275&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;334&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;254&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;335&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;394&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;314&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;395&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;454&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&amp;gt;&lt;input name="getSeqGi" value="42719009" type="checkbox"&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/nucleotide/42719009?report=genbank&amp;amp;log$=nuclalign&amp;amp;blast_rank=3&amp;amp;RID=7M4JGPM4011" title="Show report for AY464947"&gt;&lt;span style="font-size:10.0pt;font-family: &amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;;color:blue"&gt;gb|AY464947.1|&lt;/span&gt;&lt;/a&gt;&lt;a name="42719009"&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=nucleotide&amp;amp;cmd=Display&amp;amp;dopt=nucleotide_unigene&amp;amp;from_uid=42719009&amp;amp;RID=7M4JGPM4011&amp;amp;log$=unigenealign&amp;amp;blast_rank=3"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" alt="Description: UniGene info linked to AY464947.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&amp;amp;cmd=search&amp;amp;term=42719009%5bNUID%5d&amp;amp;RID=7M4JGPM4011&amp;amp;log$=genealign&amp;amp;blast_rank=3"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image003.gif" alt="Description: Gene info linked to AY464947.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?direct=on&amp;amp;gbgi=42719009&amp;amp;THE_BLAST_RID=7M4JGPM4011&amp;amp;log$=mapalign&amp;amp;blast_rank=3"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue;mso-no-proof:yes;text-decoration:none;text-underline:none"&gt;&lt;span style="mso-ignore:vglayout"&gt;&lt;img src="file:///C:/Users/KIRANB%7E1/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" alt="Description: Genome view with mapviewer linked to AY464947.1" border="0" height="16" width="16" /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Arabidopsis thaliana spiral1 (SPR1) mRNA, complete cds&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Length=646&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;&lt;/span&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&amp;amp;cmd=search&amp;amp;term=814896&amp;amp;RID=7M4JGPM4011&amp;amp;log$=geneexplicitnucl&amp;amp;blast_rank=3"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;; color:blue"&gt;GENE ID: 814896 SPR1&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:10.0pt; font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; | spiral1 [Arabidopsis thaliana]&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;(10 or fewer PubMed links)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Score =&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;628 bits (340),&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;Expect = 2e-178&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Identities = 350/360 (97%), Gaps = 0/360 (0%)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt; &lt;/span&gt;Strand=Plus/Plus&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;14&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCT&lt;span style="color:gray"&gt;nnnnnnnnnn&lt;/span&gt;TCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;73&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;|||||||||||||||||||||||||||||||||||||&lt;span style="mso-spacerun:yes"&gt;          &lt;/span&gt;|||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;82&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;ATGGGTCGTGGAAACAGCTGTGGTGGAGGTCAAAGCTCATTGGATTATCTCTTTGGTGGT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;141&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;74&lt;span style="mso-spacerun:yes"&gt;   &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;133&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;142&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GACGCTCCTGCTCCTAAGCCAGTTCCAGCTCCTCGTCCCGCTCCTACTGAGTCTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;201&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;134&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;193&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;202&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GGACCTGCACCACCAGTAACAGCTGTGACTGCAACCGCACTCACGACTGCTACTACTTCT&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;261&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;194&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;253&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;262&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTGAGCCTGCAGAGCTTAACAAGCAGATTCCTGCTGGTATCAAAACTCCTGTTAACAAC&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;321&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;254&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;313&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;322&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;TATGCCAGAGCTGAAGGACAGAACACCGGCAACTTCCTCACTGACCGTCCTTCGACCAAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;381&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Query&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;314&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;373&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;&lt;span style="mso-spacerun:yes"&gt;            &lt;/span&gt;||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Sbjct&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;382&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;GTTCACGCAGCTCCGGGAGGAGGATCATCCTTGGATTATCTCTTCACTGGTGGCAAGTAA&lt;span style="mso-spacerun:yes"&gt;  &lt;/span&gt;441&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal;tab-stops:45.8pt 91.6pt 137.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6pt 595.4pt 641.2pt 687.0pt 732.8pt"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Courier New&amp;quot;;mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;span style="font-size:100%;"&gt;  &lt;/span&gt;&lt;p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height: normal"&gt;&lt;span style="Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;font-size:100%;" &gt; &lt;/span&gt;&lt;/p&gt;  &lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-5315563276700772851?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/5315563276700772851'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/5315563276700772851'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/sequencing-spr1-gene.html' title='Sequencing SPR1 gene'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/-Rxa6EFtRkSQ/TnpvTkZ1YMI/AAAAAAAAARk/azawVUrVxlo/s72-c/Untitled.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-1096467442490352606</id><published>2011-09-22T04:12:00.006+05:30</published><updated>2011-09-22T05:18:47.394+05:30</updated><title type='text'>Failed</title><content type='html'>&lt;div style="text-align: justify;"&gt;Failed to obtain result of qRT-PCR. This is the first time that I did Real Time PCR. I was expecting enhanced expression of tatA, tatC and per - genes in presence of iron among WT and fur-mutant Listeria monocytogenes. 16S rRNA gene was used as an endogenous control. The most surprising thing is that none of the 3 x 3 x 2 x 4 = 72 reactions was observed with characteristic sigmoid curve; rather all the lines were in log phase only without labeling off. So, the instrument could not calculate Ct value for any of the reaction triplicates. My instructor mentioned that I did wrong somewhere during reaction preparation. However, my boss suspects on quantification of mRNAs and/or cDNAs. Only the thing that I know is I failed the experiment at the first time. I was so scared to report the case to my professor. However, he simply said me to repeat the experiment. I have started right from the beginning - growing bacteria.&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-1096467442490352606?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1096467442490352606'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1096467442490352606'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/failed.html' title='Failed'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-8252602925701385874</id><published>2011-09-15T05:48:00.003+05:30</published><updated>2011-09-15T07:30:57.978+05:30</updated><title type='text'>Limitation</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/-Y2Ky0bJk81g/TnFcNvF5G8I/AAAAAAAAARc/6eDEnqEYK34/s1600/Father.jpg"&gt;Only the limitation that I (we) have is  - we do not have our beloved father. Have everything, besides.&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/-Y2Ky0bJk81g/TnFcNvF5G8I/AAAAAAAAARc/6eDEnqEYK34/s1600/Father.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px; height: 310px;" src="http://3.bp.blogspot.com/-Y2Ky0bJk81g/TnFcNvF5G8I/AAAAAAAAARc/6eDEnqEYK34/s320/Father.jpg" alt="" id="BLOGGER_PHOTO_ID_5652400398375918530" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-8252602925701385874?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/8252602925701385874'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/8252602925701385874'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/limitation.html' title='Limitation'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/-Y2Ky0bJk81g/TnFcNvF5G8I/AAAAAAAAARc/6eDEnqEYK34/s72-c/Father.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-4900388906113336764</id><published>2011-09-02T05:19:00.001+05:30</published><updated>2011-09-02T05:19:59.134+05:30</updated><title type='text'>Cell Biology</title><content type='html'>&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Cell Biology:&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;    &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Hey, its Molecular Biology of the Cell. Ya, Molecular Biology. I had to study it, studied. With the great difficulty, I went through some portion of it. Got it. Felt it. &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;    &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;And, probably, you know what I mean. I had an understanding that without knowing the Molecular Biology of eukaryotic cells, one (at least me) could not understand completely the Microbiology. Not all, in my opinion (may be wrong), most of the microbes are in direct or indirect influence of eukaryotic system. Their physiology cannot be understood without, at least, comparing to that of eukaryotes.&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;    &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Now-a-days, I have a great relief, in my important time, that I carried my understanding of Cell Biology to abroad. The subject that I taught for more than six years in Universal Science College (the then in Maitidevi, Kathmandu) is becoming my tool to understand my Microbiology further.&lt;/span&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-4900388906113336764?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/4900388906113336764'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/4900388906113336764'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/09/cell-biology.html' title='Cell Biology'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-4536708259360934694</id><published>2011-08-31T08:40:00.002+05:30</published><updated>2011-08-31T08:50:34.687+05:30</updated><title type='text'>Hurricane!!! Tornedo!!! Sometimes go for better!!!</title><content type='html'>&lt;div style="text-align: justify;"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Hurricane!!! Tornedo!!! Sometimes go for better!!!&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;How many bacteria are present in a microcentrifuge after spinning of overnight log phase growth to extract plasmid? How many plates can be made in a day or week by a student? How many sterile swabs can be prepared? &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;A mass. The mass can engulf me, you too. Its good. The quality control and efficiency!!! The level of discourse!!! Where we are? I am on the bottom. What did I know? No nothing at all. But insignificant with respect to current time wave. I need to modify myself even in some principles. For example: 5’ cap and 3’ polyA tail of mRNA are for stability, 20,000 – 50,000 genes are present in human, average size of human gene is about 3kbp, two parts of core promoter of a promoter, only 1% of total human chromosome contains protein coding parts, more than 90% of the genes in human have alternate splicing modes, psedogenes, any functional noncoding repeats in DNA (chromosome), two mRNA can be fused to form a new mRNA, 51.1% maternal and 49.9% paternal contribution in human offsprings, etc.&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Ya, it hurts. My leg hurts. However, I know this only when other people ask whether your leg hurts or not. I usually forget this for rest of the time in each day. Oh! I should not lie: it hurts when I came to my apartment after the day of work. More than this, my heart hurts. Ya, heart hurts. I didn’t get the chance to soothe it in my home (professional). Expectations were as usual because I did what I know, what I can, what I do best, best for all. Not intentional. &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Definitely, missing everyone: mom, wife, brother, sister and her family, son, and all other relatives. All professional relatives. Everything including mustard oil, “besar (I do not know its English name)”, tea. Tears in the eyes: in Kathmandu, Chicago and Illinois – for days. No internet, no phone……!!! Now, I have talked better. Have those. &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Hummmm, one thing I should not hide: I regularly have bath in the morning.&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;Besides my family and all relatives, I, especially, remember those who helped me coming out of one of the difficult moments in the last January. I want to copy of my wall post in my FB (&lt;a href="http://www.facebook.com/notes/kiran-babu-tiwari/new-life/180499728657547"&gt;http://www.facebook.com/notes/kiran-babu-tiwari/new-life/180499728657547&lt;/a&gt;) posted &lt;/span&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;on Thursday, January 20, 2011 at 6:05am: “Just arrived in home for rest of more than a month after two weeks stay in TU Teaching Hospital due to tragic motorcycle crash..... Am thanking to all who helped me getting new life. Equally to all relatives and friends, I especially am thankful for Prof. Rijal, the nurse in Mananmohan Hospital, Dr. Banjara and his brother, Prof. Tiwari, All medical staffs in TUTH emergency unit. Equally, to Dr. Arjun Lamichhane and Dr. Deepak Mahara's operation team, all the nurses / attendants plus my core family members (with Sanobuwa/Sanima/Kan6idd/Bhai), friends of my brother and Sharmila. I beg sorry if I lost any name involved in the help.”&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;My sincerity goes to Pradeep sir who gave me a break in Tri-Chandra College, eventhough............&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;I, always, feel thankfulness and appreciation to Nabaraj sir who helped me to the extreme in those days when I could not move here and there. He picked me up and rode to different colleges and, always, finally to my home. I won't forget such help that I got in my life from him. I haven't have any word to describe his avail.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size: 12pt; font-family: &amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;;"&gt;Dear Ramesh dai, who inspired me for hard work, I love you forever.&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Remembering all my friends.....................................&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Will write rest.&lt;/span&gt;&lt;/p&gt;&lt;div style="text-align: justify;"&gt;  &lt;/div&gt;&lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; line-height: normal; text-align: justify;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;; mso-fareast-font-family:&amp;quot;Times New Roman&amp;quot;"&gt;Enjoy.&lt;/span&gt;&lt;span style="font-size: 12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;,&amp;quot;serif&amp;quot;"&gt;&lt;/span&gt;&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-4536708259360934694?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/4536708259360934694'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/4536708259360934694'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/08/hurricane-tornedo-sometimes-go-for.html' title='Hurricane!!! Tornedo!!! Sometimes go for better!!!'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-7750345207041588177</id><published>2011-08-27T18:08:00.000+05:30</published><updated>2011-08-27T18:09:14.984+05:30</updated><title type='text'>New world</title><content type='html'>&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:officedocumentsettings&gt;   &lt;o:allowpng/&gt;  &lt;/o:OfficeDocumentSettings&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:enableopentypekerning/&gt;    &lt;w:dontflipmirrorindents/&gt;    &lt;w:overridetablestylehps/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal"&gt;The way diverted to the direction where I should have been (already). I could not be able to get the way without the others' hands and minds, thanks to them. I am very much thankful to you all who helped me track the way. Equally, I am thankful to those who didn't help me get across the thing that I wanted to be done. More than this, I thank to those hands and masterminds who forced me to make a bridge over the oceans. I haven't have any complains to anybody, and won't have. This is because, I never had any intention to misbehave anyone anywhere. Just cool.&lt;/p&gt;  &lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-7750345207041588177?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/7750345207041588177'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/7750345207041588177'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/08/new-world.html' title='New world'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-6860912194467627662</id><published>2011-08-08T20:33:00.002+05:30</published><updated>2011-08-08T20:34:19.699+05:30</updated><title type='text'>Ganesh ji</title><content type='html'>&lt;a href="http://2.bp.blogspot.com/-2oav9DM_1Vw/Tj_65D1oYTI/AAAAAAAAARU/1b7nPYJjxOI/s1600/G.JPG"&gt;&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 245px; DISPLAY: block; HEIGHT: 320px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5638501116680888626" border="0" alt="" src="http://2.bp.blogspot.com/-2oav9DM_1Vw/Tj_65D1oYTI/AAAAAAAAARU/1b7nPYJjxOI/s320/G.JPG" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;div&gt;&lt;/div&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-6860912194467627662?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6860912194467627662'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6860912194467627662'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/08/ganesh-ji.html' title='Ganesh ji'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/-2oav9DM_1Vw/Tj_65D1oYTI/AAAAAAAAARU/1b7nPYJjxOI/s72-c/G.JPG' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-2492070689612536254</id><published>2011-07-16T11:21:00.004+05:30</published><updated>2011-07-17T07:41:17.248+05:30</updated><title type='text'>Finally, the book has been published</title><content type='html'>&lt;img style="TEXT-ALIGN: center; MARGIN: 0px auto 10px; WIDTH: 214px; DISPLAY: block; HEIGHT: 320px; CURSOR: hand" id="BLOGGER_PHOTO_ID_5629824474311274290" border="0" alt="" src="http://3.bp.blogspot.com/-WFtIkEzE-_4/TiEniAMfrzI/AAAAAAAAAQo/62LZTzqHuAY/s320/Published%2Bbook%2B1.1.JPG" /&gt;&lt;br /&gt;Finally my book has published from Kantipur College of Medical Science, Sitapaila, Kathmandu.&lt;br /&gt;&lt;br /&gt;......................................................................................&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Contact:&lt;/strong&gt;&lt;br /&gt;Kiran Babu Tiwari (Author): &lt;a href="mailto:kbtiwaree@gmail.com"&gt;kbtiwaree@gmail.com&lt;/a&gt;, 00977-9841-374738&lt;br /&gt;College: 00977-1-4279723&lt;br /&gt;&lt;br /&gt;...................................................................................&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Preface:&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;Working for years in Central Department of Microbiology, I felt the necessity of a practical hand book on Microbial Genetics and Molecular Biology as a text book with the practical specially designed towards the M. Sc. Microbiology course of Tribhuvan University, Nepal. The aim of this book is to provide basic and advanced practical exercises in microbial genetics and molecular biology useful for masters’ level students and a guideline material for the tutors as well.&lt;br /&gt;&lt;br /&gt;While writing this manual, I considered our limited resources and the need to develop experiments that can illustrate and develop concepts in microbial genetics and molecular biology. So the experiments which have been included in the hand book could be carried out in our country context as well.&lt;br /&gt;&lt;br /&gt;The hand book explains experiment in such a way that students can understand objectives and principles before starting the procedure. Procedural sections are also written to make the students and tutor/s understand the sequential flow of steps to be carried out. We tried to start from the very beginning: from micropipette calibration through DNA / RNA extraction, analysis of analyte, qualitative and quantitative determination of lac-operon, conjugation, transformation, DNA cloning, PCR to Restriction mapping. Some of the useful information is also attached under annexes. This is one of the efforts to make students and tutors easy in designing and performing experiments. We hope this book will equally be useful to other disciplines of biomedical sciences. Any comments, suggestions for improving this book/manual will be highly appreciated.&lt;br /&gt;&lt;br /&gt;I am indebted to Prof. Dr. Shital Raj Basnyat for writing forewords for this book.&lt;/div&gt;&lt;br /&gt;.....................................................................................&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Contents:&lt;/strong&gt;&lt;br /&gt;CONTENTS&lt;br /&gt;&lt;br /&gt;Orientation: Orientation of Microbial genetics / Molecular Biology Laboratory.................1&lt;br /&gt;&lt;br /&gt;Principles: Principle of nucleic acids isolation from bacteria .............................................3&lt;br /&gt;&lt;br /&gt;Experiment 1: Calibration of micropipettes ..................5&lt;br /&gt;&lt;br /&gt;Experiment 2: Preparation of Tris buffers: Tris-HCl, Tris-EDTA and TAE ....................................7&lt;br /&gt;&lt;br /&gt;Experiment 3: Isolation of DNA from human blood......10&lt;br /&gt;&lt;br /&gt;Experiment 4a: Extraction of chromosomal DNA from Gram positive bacteria .......................12&lt;br /&gt;&lt;br /&gt;Experiment 4b: Extraction of chromosomal DNA from Gram negative bacteria ......................14&lt;br /&gt;&lt;br /&gt;Experiment 4c: DNA extraction from yeasts ................16&lt;br /&gt;&lt;br /&gt;Experiment 4d: Isolation of nucleic acid (DNA / RNA) from Coliphages .......................................18&lt;br /&gt;&lt;br /&gt;Experiment 5a: Extraction of Plasmid DNA from bacteria .......................................................20&lt;br /&gt;&lt;br /&gt;Experiment 5b: Isolation and purification of bacterial plasmids using Qiagen spin Miniprep system .............................................22&lt;br /&gt;&lt;br /&gt;Experiment 6a: Extraction of RNA from yeasts .............30&lt;br /&gt;&lt;br /&gt;Experiment 6b: Extraction of RNA from bacteria ..........32&lt;br /&gt;&lt;br /&gt;Experiment 7: Spectrophotometric analysis of DNA in extracted solution ..............................34&lt;br /&gt;&lt;br /&gt;Experiment 8: Agarose gel electrophoresis of DNA.......36&lt;br /&gt;&lt;br /&gt;Experiment 9a: Demonstration of induction/repression mode of lac-operon regulation system in Escherichia coli..................................40&lt;br /&gt;&lt;br /&gt;Experiment 9b: Determination of level of induction of lac-operon in Escherichia coli....................42&lt;br /&gt;&lt;br /&gt;Experiment 10: Conjugation in bacteria: Co-culture of MDR Salmonella enteritidis Typhi with Escherichia coli HB101 and detection of transconjugants by antibiotic selection method.............................................44&lt;br /&gt;&lt;br /&gt;Experiment 11: Transformation of Escherichia coli HB101 by pUC18 or pBR322..........................46&lt;br /&gt;&lt;br /&gt;Experiment 12: Study of performance of HindIII and EcoRI Restriction enzymes stored in lab.........49&lt;br /&gt;&lt;br /&gt;Experiment 13a: Construction of recombinant DNA: Preparation and purification of insert (Lambda DNA fragments) and vector (pUC18) DNA ....................................54&lt;br /&gt;&lt;br /&gt;Experiment 13b: Construction of recombinant DNA: Ligation of purified insert (Lambda DNA fragments) and vector (pUC18) DNA.....57&lt;br /&gt;&lt;br /&gt;Experiment 14a: Amplification of recombinant DNA: Transformation of recombinant pUC18 DNA in Escherichia coli HB101 .............59&lt;br /&gt;&lt;br /&gt;Experiment 14b: Detection of recombinant DNA: Extraction of recombinant pUC18 DNA from transformed Escherichia coli HB101 clones .......................................................61&lt;br /&gt;&lt;br /&gt;Experiment 14c: Detection of recombinant DNA: Detection of recombinant pUC18 DNA in plasmid extracts of transformed Escherichia coli HB101 clones by agarose gel electrophoresis .................................63&lt;br /&gt;&lt;br /&gt;Experiment 15a: Amplification of Escherichia coli DNA (genes) by Polymerase Chain Reaction (PCR) ................................................65&lt;br /&gt;&lt;br /&gt;Experiment 15b: Randomly Amplified Polymorphic DNA – Polymerase Chain Reaction (RAPD-PCR) .......................................................68&lt;br /&gt;&lt;br /&gt;Experiment 16: Bacterial plasmid profiling....................71&lt;br /&gt;&lt;br /&gt;Experiment 17: Construction of simple restriction map of a plasmid DNA .....................................73&lt;br /&gt;&lt;br /&gt;ANNEXES&lt;br /&gt;&lt;br /&gt;Annex I: Molecular Biology components ............76&lt;br /&gt;&lt;br /&gt;Annex IIa: Preparation of buffers.........................78&lt;br /&gt;&lt;br /&gt;Annex IIb: Tri buffers ........................................81&lt;br /&gt;&lt;br /&gt;Annex III: Phenol .............................................83&lt;br /&gt;&lt;br /&gt;Annex IV: Bacterial nucleoid staining ..................85&lt;br /&gt;&lt;br /&gt;Annex V: Antibiotic susceptibility testing (AST) of bacteria ...........................................86&lt;br /&gt;&lt;br /&gt;Annex VI: Broth dilution method to determine Minimum inhibitory concentration (MIC) .......................................................88&lt;br /&gt;&lt;br /&gt;Annes VII: Generation of actinomycete mutants using sodium azide and their analysis..........89&lt;br /&gt;&lt;br /&gt;Annex VIII: Replica plating ..................................91&lt;br /&gt;&lt;br /&gt;Annex IX: Ames test .........................................94&lt;br /&gt;&lt;br /&gt;Annex X: Determination of ciprofloxacin related mutation rate in wild type Salmonella typhi................................................98&lt;br /&gt;&lt;br /&gt;Annex XI: Marker - 1 Kb ladder DNA..................100&lt;br /&gt;&lt;br /&gt;Annex XIIa: Escherichia coli host strains for transformation ................................102&lt;br /&gt;&lt;br /&gt;Annex XIIb: Alpha-Complementation ...................106&lt;br /&gt;&lt;br /&gt;Annex XIIIa: Construction of simple restriction map of pBR322 using PstI, HindIII and EcoRI ......................................................107&lt;br /&gt;&lt;br /&gt;Annex XIIIb: pUC vectors ....................................111&lt;br /&gt;&lt;br /&gt;Annex XIIIc: pBR322 vector ...............................113&lt;br /&gt;&lt;br /&gt;Annex XIV: Star activity of Restriction enzymes ....114&lt;br /&gt;&lt;br /&gt;Annex XV: PCR calculations ..............................117&lt;br /&gt;&lt;br /&gt;Annex XVI: Southern Blotting ............................120&lt;br /&gt;&lt;br /&gt;Annex XVII: Ethidium bromide ............................123&lt;br /&gt;&lt;br /&gt;Annex XVIII: Molarity of HCl ................................128&lt;br /&gt;&lt;br /&gt;Bibliography: Bibliography ....................................129&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-2492070689612536254?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2492070689612536254'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2492070689612536254'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/07/finally-book-is-published.html' title='Finally, the book has been published'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/-WFtIkEzE-_4/TiEniAMfrzI/AAAAAAAAAQo/62LZTzqHuAY/s72-c/Published%2Bbook%2B1.1.JPG' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-3952338117514190636</id><published>2011-05-19T20:53:00.003+05:30</published><updated>2011-05-19T21:23:54.837+05:30</updated><title type='text'>Am optimistic</title><content type='html'>I am optimistic to the latest result from Service Commission (Sewa Aayog) - 2011 (BS 2068), Tribhuvan University; I failed the exam. I understand those who passed did well than what I did. Its true that I am not eligible to teach under a permanent job in the university. However I am doing, at least, my best whereever am working. I congratulate all of them.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-3952338117514190636?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3952338117514190636'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3952338117514190636'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/05/am-optimistic.html' title='Am optimistic'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-2123680801182195158</id><published>2011-04-12T13:22:00.002+05:30</published><updated>2011-04-12T13:28:36.598+05:30</updated><title type='text'>New taste</title><content type='html'>Working in Tri-Chandra Multiple college is becoming a new taste on me.&lt;br /&gt;&lt;br /&gt;Though I wanted to have the taste long ago, I could get some classes to hypnotize people at the 11th hour. The thirst was to self hypnotize my scientific brain after washing hands (made me wash my hands) from Central Department of Microbiology, Tribhuvan University, Kirtipur, where I worked for more than five years.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-2123680801182195158?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2123680801182195158'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/2123680801182195158'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/04/new-taste.html' title='New taste'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-6388859496457978705</id><published>2011-04-12T13:09:00.001+05:30</published><updated>2011-04-12T13:20:12.896+05:30</updated><title type='text'>Directed molecular evolution of broadly crossreactive glycoproteins as modern concept of HIV-vaccine</title><content type='html'>BIOTECHNOLOGY SOCIETY OF NEPAL (BSN) E-BULLETIN&lt;br /&gt;VOLUME 2, NOVEMBER 2010&lt;br /&gt;w w w . b s n . o r g . n p i n f o @ b s n . o r g . n p&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Review Article&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;span style="font-size:130%;"&gt;Directed molecular evolution of broadly crossreactive glycoproteins as modern concept of HIV-vaccine&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Kiran Babu Tiwari1&lt;br /&gt;&lt;/strong&gt;1Central Department of Microbology, Tribhuvan University, Kirtipur, Nepal&lt;br /&gt;Tel.: 9841374738, Email: &lt;a href="mailto:gp120cdnashuffling@gmail.com"&gt;gp120cdnashuffling@gmail.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;br /&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;Development of broadly crossreactive immunogen is utmost important as effective vaccine against HIV. Various methods are employed to develop model vaccines against HIV worldwide; however, none of the attempt became successful yet. Recently, directed molecular evolution of viral surface glycoproteins is being developed to create broadly crossreactive immunogen mimicking natural recombination in HIV.&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;br /&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: DNA shuffling, HIV, hyperrecombination, vaccine&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;/div&gt;&lt;br /&gt;&lt;div align="justify"&gt;&lt;strong&gt;Link&lt;/strong&gt;: &lt;a href="http://www.bsn.org.np/ebulletin/vol2/"&gt;http://www.bsn.org.np/ebulletin/vol2/&lt;/a&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-6388859496457978705?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6388859496457978705'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6388859496457978705'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/04/directed-molecular-evolution-of-broadly.html' title='Directed molecular evolution of broadly crossreactive glycoproteins as modern concept of HIV-vaccine'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-6177191885937341206</id><published>2011-03-26T08:17:00.002+05:30</published><updated>2011-03-26T08:21:36.770+05:30</updated><title type='text'>Philosophy of Molecular Genetics</title><content type='html'>&lt;strong&gt;Philosophy of Molecular Genetics&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;1. Principles of genetics&lt;br /&gt;&lt;/strong&gt;Two contradictory principles&lt;br /&gt;      1. Fidelity&lt;br /&gt;      2. Evolution&lt;br /&gt;Biochemical mechanisms underlying the contradictory requirements for both genetic continuity and the evolution of living organisms&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Fidelity:&lt;br /&gt;&lt;/strong&gt;Many bacteria have nearly same size, shape and internal structures and contain same kinds of precursor molecules and enzymes for 4 billions years&lt;br /&gt;Consistent continuity of inherited traits over millions of years&lt;br /&gt;Transmission of genetic information from generation to generation with high fidelity&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;DNA polymerase:&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;•         Multisubunit complex&lt;br /&gt;•         H-bonding crosschecks&lt;br /&gt;•         Processivity, Proofreading&lt;br /&gt;•         Error rates: 10-2 - 10-3 (assumed)&lt;br /&gt;•         10-6 - 10-8 (proofreading)&lt;br /&gt;•         10-10 (Mismatch repair and other repair mechanisms)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Structural complementarity&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;•         Any error on one strand can be repaired with the help of complementary strand&lt;br /&gt;•         Otherwise – SOS Response in bacteria&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Evolution:&lt;br /&gt;&lt;/strong&gt;•         Despite the near perfect fidelity of genetic replication&lt;br /&gt;            Infrequent, un-repaired mistakes in the DNA replication occurs&lt;br /&gt;•         Change in Ntd sequence or Incorrectly repaired damage -- Changing the instructions for some cellular components -- Handled down to offspring&lt;br /&gt;•         Some lethal mutations – organism perish away&lt;br /&gt;•         Occasionally a mutation better equips an organism or cell to survive in new environment&lt;br /&gt;•         Slightly different specificity (new metabolism): selective advantage to wild type – survive – propel in the new environment&lt;br /&gt;•         Occasionally, whole genome is duplicated&lt;br /&gt;•         Second copy is superfluous and mutation is not deleterious - new gene/function&lt;br /&gt;Several billions years of adaptive selection have refined cellular systems to take maximum advantage&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Genetic material&lt;br /&gt;&lt;em&gt;The molecular nature of genetic material: Why DNA or RNA?&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;      1. Template surfaces for new copy synthesis&lt;br /&gt;      2. Template must be in the size range of their products&lt;br /&gt;      3. Attraction of opposite versus self&lt;br /&gt;      – proteins with aminoacid side chains&lt;br /&gt;      – AA should attract same (no specificity) or other (chemically not stable)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Protein as not a good template:&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;      - Val n Ala 1CH3, Val n Iso 1CH3, Gly n Ala 1CH3&lt;br /&gt;      – difficult to discriminate&lt;br /&gt;      – accounts about 108 times more discrimination strength over Ntd&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Proofs for NA as genetic materials&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;1. Establishing the chemical constitutes of DNA and RNA&lt;br /&gt;2. - 1928: English Microbiologist Fredrick Griffith Transformation&lt;br /&gt;           - 1944 – a 10yrs of continuous research American Microbiologist Ostwald T. Avery and his colleagues Colin M MacLeod and Maclyn McCarty at Rockfeller Institute, NY isolated DNA as transforming agent&lt;br /&gt;3. Constant amount of DNA: Beef tissue: Thymus 6.6pg, liver  6.4pg, pancreas 6.9pg, kidney 5.9pg, sperm 3.3pg&lt;br /&gt;4. Chargaff’s rule: Erwin Chargaff 1949: College of Physicians and Surgeons of columbia university&lt;br /&gt;5. W&amp;amp;C 1953: dsDNA&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;DNA&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;•         Anti-parallel and helical: to fit ribose residues internally&lt;br /&gt;•         Complementatrity: to make the sense of double strandedness (DS)&lt;br /&gt;•         DS: stabilization by: (a) H-bond, (b) base stacking interactions (largely nonspecific)&lt;br /&gt;•         Repair – mismatch / SOS&lt;br /&gt;•         Recombination – homologous / site specific&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;DNA vs RNA&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Why DNA is preferred over RNA? Why DS? Why complementarity?&lt;br /&gt;Answer: for repair and stability&lt;br /&gt;(RNA spontaneous hydrolysis)&lt;br /&gt;Double strandedness of DNA: How?&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;2’-OH of Ribose sugar&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Electronegativity of O atom within the vicinity of helix&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Rate of NA metabolism&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Rate of synthesis and turnover&lt;br /&gt;DNA: 1 turnover/cell cycle; RNA: higher rate&lt;br /&gt;DNA: Master molecule; RNAs: Tools&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Level of jobs&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;DNA: precise replication, passively assist in transcription&lt;br /&gt;RNAs: Extensive (genome, structural, mediator, enzyme)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Why does DNA not contain U?&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Uridyl DNA glycosylase&lt;br /&gt;Primitive DNA might contain U&lt;br /&gt;However, U can be problematic&lt;br /&gt;Double carboxy groups per U&lt;br /&gt;Higher rate of tautomer formation&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;de novo synthesis&lt;br /&gt;1. DNA&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;1 turnover/per cell cycle,&lt;br /&gt;Master storage for information,&lt;br /&gt;Built in for lowest error rate&lt;br /&gt;•         Initial events always error prone&lt;br /&gt;•         Must be corrected (removed) later on&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;RNA primer&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Shorter length&lt;br /&gt;Recognition efficiency&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;2. RNA&lt;br /&gt;&lt;/strong&gt;Can be synthesized when required&lt;br /&gt;Can be replaced by newer copy&lt;br /&gt;Shorter half life (rapid turnover),&lt;br /&gt;So, less precision as higher investment for higher precision&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Super-coiling in chromosome : Compact vs Access????&lt;br /&gt;&lt;/strong&gt;•         Supercoiling: when DNA is subject to some form of structural strains&lt;br /&gt;•         Underwound strain: Fewer helical turns than expected in B form&lt;br /&gt;84 / 10.5 = 8&lt;br /&gt;For 7 = 84 / x,  x = 12 (12 &gt; 10.5)&lt;br /&gt;•         Strain is accompanied by coiling of axis of DNA on itself to form supercoil&lt;br /&gt;•         Accommodated by separating two strands over 10.5 Ntd bases length&lt;br /&gt;•         As coiling requires less energy than breaking H-bonds that stabilize paired bases&lt;br /&gt;Underwound - easy access&lt;br /&gt;Loosened compact&lt;br /&gt;Easier to separate strands&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Higher mutation rates in Virus&lt;br /&gt;&lt;/strong&gt;            Mostly single stranded RNA&lt;br /&gt;            Error prone RNA dependant RNA polymerase than DNA dependant RNA polymerase&lt;br /&gt;            (that requires ds DNA for transcription)&lt;br /&gt;            Highest mutation rates in RNA viruses&lt;br /&gt;            Recombination – HIV (diploid genome)&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Overlapping genes&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Small sized virus to have more number of genes&lt;br /&gt;However effect of mutation&lt;br /&gt;So, better to separate if can be accommodated larger NA&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Bacteria&lt;br /&gt;&lt;/strong&gt;1. &lt;strong&gt;&lt;em&gt;Why single replicon?&lt;/em&gt;&lt;/strong&gt; – small unicellular, small chromosome, easy controlling&lt;br /&gt;2. &lt;strong&gt;Why higher rate of molecular turnover than eukaryotes?&lt;br /&gt;&lt;/strong&gt;            Size of replicon: Bacteria = 4.6X106Kb, Yeast = 40Kb, Animal = 100Kb&lt;br /&gt;            Rate of regional control: Bacteria = 50Kbp/min, Eukaryotes = 2Kbp/min, 1hr/6hr (15% at a time)&lt;br /&gt;3. &lt;strong&gt;&lt;em&gt;Why microscopic size? –&lt;/em&gt;&lt;/strong&gt; simple, unicellular (high SA / Vol): So, larger surface for small body&lt;br /&gt;4. &lt;strong&gt;&lt;em&gt;Why haploid?&lt;/em&gt;&lt;/strong&gt; – small sized body, only for the metabolic needs, limits the cellular components, lesser quantity of chromosome&lt;br /&gt;5.&lt;strong&gt;&lt;em&gt; Why operon (polycistronic)?&lt;/em&gt;&lt;/strong&gt; – small quantity of genome, so related genes must be under a control system, no need of separate controlling strategies that may involve more components -  global control&lt;br /&gt;6.&lt;strong&gt;&lt;em&gt; Why negative regulation for lac-operon?&lt;/em&gt;&lt;/strong&gt; – Lactose is secondary sugar, primary and ubiquitous is glucose, so presence of glucose should avoid lactose as its metabolism need extra enzymatic step and regulatory apparatus, so should be repressed until need&lt;br /&gt;&lt;strong&gt;&lt;br /&gt;Organism transition: Prok to Euk&lt;br /&gt;&lt;/strong&gt;•         2B (2X103X103X103) yrs from prokaryotes&lt;br /&gt;•         Cellular communication among differentiated cells/organs&lt;br /&gt;•         3 major changes&lt;br /&gt;•         More DNA  - fold to compact and discrete complex&lt;br /&gt;•         Cells become larger – increased compartmentalization -- Nuclear envelop&lt;br /&gt;•         Early eukaryotes - anaerobic – aerobic photosynthetic bacterial symbiosis created photosynthetic plants&lt;br /&gt;&lt;br /&gt;•         &lt;strong&gt;&lt;em&gt;Organism evolution&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;•         Unicellular organisms – advantageous to cluster together for cooperative mobility, efficiency and reproductive successes – permanent associations among individual cells – colony – cellular differentiation&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Eukaryotes:&lt;br /&gt;&lt;em&gt;Why introns?&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;To dilute the rate of mutation as eukaryotic genome is very larger compared to that of bacteria&lt;br /&gt;Larger chromosome - higher probability of random mutation, So incorporation of noncoding sequences largely dilute the effect of mutation within the genes, And, introns are removed during RNA processing&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;2. Why alleles (diploidy)?&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Many introns, however, can increase mutation during processing of RNA with 1 or more Ntd remaining from intron sequence or loss of one or more Ntd from exons. Better to have copies of the gene in homologous positions in the chromosomes, some genes are present in multicopiess&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;3. Why not operons?&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Eukaryotes are more complex having many more components and regulation systems in the cell&lt;br /&gt;Many of the functions can go lethal when aberrant,&lt;br /&gt;Having operon with a control region for some to many genes – single change in the promotor can destroy the operon function killing all the gene,&lt;br /&gt;Moreover, as larger quantity of the DNA can be accommodated, no burden to have separate system of control&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;4. Why positive regulation of gene expression? &lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Bacteria: nonrestrictive transcriptional ground state&lt;br /&gt;•               RNA polymerase find every promoter in the absence of activators or repressors&lt;br /&gt;&lt;br /&gt;Eukaryotes: restrictive transcriptional ground state&lt;br /&gt;•         Strong promoters are generally inactive in vivo in the absence of regulatory proteins&lt;br /&gt;&lt;br /&gt;Restrictions:&lt;br /&gt;      1.  by the structure of chromatin (Chromatin remodulation)&lt;br /&gt;      2.  Transcription and translation separation in both space and time&lt;br /&gt;      3. Positive regulation: virtually every eukaryotic gene requires activator for transcription&lt;br /&gt;     &lt;br /&gt;In positive regulation, most of the genes are normally inactive: The cell synthesizes only the activator proteins needed to promote transcription of the subset of genes required in the cell at that time&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Why nuclear envelop?&lt;br /&gt;&lt;/strong&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Sex in not absolutely necessary&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;Single celled organisms: mitotic division&lt;br /&gt;Many plants: vegetative propagation&lt;br /&gt;Hydra: budding&lt;br /&gt;Sea anemones and marine worms: splitting into halves&lt;br /&gt;Lizards: only female&lt;br /&gt;So, why sexual reproduction ??&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Benefit of sex – Recombination&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;-          Higher organisms: haploid phase – simple, brief, diploid – long and proliferation&lt;br /&gt;•         Mixing of genomes from parents: Old combinations of genes are broken up and new combinations are created&lt;br /&gt;•         Random distribution of maternal and paternal homolog chromosomes&lt;br /&gt;Possible gametes = 2n,, n = haploid no. of chrom., Human: 223 = 8.4 X 106, But, actually &gt;&gt; 223&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;&lt;em&gt;Chromosomal crossing over – prophase I of meiosis&lt;br /&gt;&lt;/em&gt;&lt;/strong&gt;2 – 3 crossovers on each homologs (chiasmata)&lt;br /&gt;competitive advantage - in an unpredictatively variable environment&lt;br /&gt;As deleterious mutations can not accumulate as bulk in a given memberLeads to the evolution of better survivor&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-6177191885937341206?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6177191885937341206'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/6177191885937341206'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2011/03/philosophy-of-molecular-genetics.html' title='Philosophy of Molecular Genetics'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-3044842074209896237</id><published>2010-11-10T11:42:00.001+05:30</published><updated>2010-11-10T11:46:50.163+05:30</updated><title type='text'>Bacterial identification charts</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_wGIqp8AxY6w/TNo4rcegvDI/AAAAAAAAAQM/nKNCsktYqKQ/s1600/Identification%2Bmap%2Bof%2BGram%2BPositive%2BRods%2B1.JPG"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="http://2.bp.blogspot.com/_wGIqp8AxY6w/TNo4rcegvDI/AAAAAAAAAQM/nKNCsktYqKQ/s320/Identification%2Bmap%2Bof%2BGram%2BPositive%2BRods%2B1.JPG" alt="" id="BLOGGER_PHOTO_ID_5537801010835143730" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_wGIqp8AxY6w/TNo4rHTmLxI/AAAAAAAAAQE/CDYZ9mrgH5I/s1600/Identification%2Bmap%2Bof%2BGram%2BPositive%2BCocci%2B1.JPG"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="http://3.bp.blogspot.com/_wGIqp8AxY6w/TNo4rHTmLxI/AAAAAAAAAQE/CDYZ9mrgH5I/s320/Identification%2Bmap%2Bof%2BGram%2BPositive%2BCocci%2B1.JPG" alt="" id="BLOGGER_PHOTO_ID_5537801005152218898" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_wGIqp8AxY6w/TNo4rKmNRiI/AAAAAAAAAP8/KTMdjooP7XI/s1600/Identification%2Bmap%2Bof%2BGram%2BNegative%2BRods%2B1.JPG"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="http://2.bp.blogspot.com/_wGIqp8AxY6w/TNo4rKmNRiI/AAAAAAAAAP8/KTMdjooP7XI/s320/Identification%2Bmap%2Bof%2BGram%2BNegative%2BRods%2B1.JPG" alt="" id="BLOGGER_PHOTO_ID_5537801006035584546" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_wGIqp8AxY6w/TNo4q5asCTI/AAAAAAAAAP0/1wU_YdJTx-I/s1600/Identification%2Bmap%2Bof%2BGram%2BNegative%2BCocci%2B1.JPG"&gt;&lt;img style="display: block; margin: 0px auto 10px; text-align: center; cursor: pointer; width: 320px; height: 240px;" src="http://4.bp.blogspot.com/_wGIqp8AxY6w/TNo4q5asCTI/AAAAAAAAAP0/1wU_YdJTx-I/s320/Identification%2Bmap%2Bof%2BGram%2BNegative%2BCocci%2B1.JPG" alt="" id="BLOGGER_PHOTO_ID_5537801001423866162" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;input id="gwProxy" type="hidden"&gt;&lt;!--Session data--&gt;&lt;input onclick="if(typeof(jsCall)=='function'){jsCall();}else{setTimeout('jsCall()',500);}" id="jsProxy" type="hidden"&gt;&lt;div id="refHTML"&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-3044842074209896237?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3044842074209896237'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/3044842074209896237'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2010/11/bacterial-identification-charts.html' title='Bacterial identification charts'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_wGIqp8AxY6w/TNo4rcegvDI/AAAAAAAAAQM/nKNCsktYqKQ/s72-c/Identification%2Bmap%2Bof%2BGram%2BPositive%2BRods%2B1.JPG' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-1828617012302524899</id><published>2010-08-09T16:57:00.003+05:30</published><updated>2010-11-07T08:04:39.095+05:30</updated><title type='text'>Contents of my book</title><content type='html'>&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;w:browserlevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Verdana; 	panose-1:2 11 6 4 3 5 4 4 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:536871559 0 0 0 415 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman";} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page WordSection1 	{size:8.5in 11.0in; 	margin:1.0in 1.0in 1.0in 1.0in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.WordSection1 	{page:WordSection1;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:"Times New Roman"; 	mso-fareast-theme-font:minor-fareast; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} &lt;/style&gt; &lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:shapedefaults ext="edit" spidmax="1026"&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;o:shapelayout ext="edit"&gt;   &lt;o:idmap ext="edit" data="1"&gt;  &lt;/o:shapelayout&gt;&lt;/xml&gt;&lt;![endif]--&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;Working  for years, I ever felt the necessity of a practical book on Microbial  Genetics and Molecular Biology as a text manual for M. Sc. Microbiology  students who are studying in the Central Department of Microbiology and  other colleges under or affiliated to Tribhuvan University, Kathmandu,  Nepal. The aim of this book is to provide them the basic and advanced  practical knowledge in the field.&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: justify;"&gt; &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-size:100%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;While  writing this manual, I considered our limited resources and facilities,  so that experiments that illustrate and develop concepts could be  conducted.&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: justify;"&gt; &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-size:100%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;The  manual explains experiments in such a way that students can understand  objectives and principles before procedure. Procedural sections are also  written to make the students and tutor/s have a sequential flow of  jobs. I tried to maintain gradient of difficulties right from  micropipette calibration through DNA / RNA extraction, analysis of  analyte, qualitative and quantitative determination of &lt;i style=""&gt;lac&lt;/i&gt;-operon,  conjugation, transformation, DNA cloning, PCR to Restriction mapping.  Many useful information / chapters are attached under annexes.&lt;br /&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: justify;"&gt; &lt;span style="font-size:100%;"&gt;&lt;br /&gt;&lt;span style="font-size:100%;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: right;" align="right"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: right;" align="right"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;Author&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: right;" align="right"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;Kiran Babu Tiwari&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: right;" align="right"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style="font-size:100%;"&gt;Central Department of Microbiology&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;div style="text-align: right;"&gt;&lt;span style="font-size:100%;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Tribhuvan University&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;p class="MsoNormal" style="text-align: center;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;CONTENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="MsoNormal" style="text-align: center;" align="center"&gt;&lt;br /&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: center;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Orientation:&lt;span style=""&gt;              &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Orientation of Microbial genetics / Molecular Biology Laboratory&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Principles: &lt;span style=""&gt;                &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Principle of nucleic acids isolation from bacteria &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 1:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;       &lt;/span&gt;Calibration of micropipettes &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 2:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;       &lt;/span&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Preparation of different Tris buffers: Tris-HCl, Tris-EDTA and TAE &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 3:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;       &lt;/span&gt;Isolation of DNA from human blood&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 4a:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Extraction of chromosomal DNA from Gram positive bacteria &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 4b:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Extraction of chromosomal DNA from Gram negative bacteria &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 4c:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;DNA extraction from yeasts &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 4d:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Isolation&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; of nucleic acid (DNA / RNA) from &lt;span style=""&gt;Coliphages &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 5a:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Extraction of Plasmid DNA from bacteria &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 5b:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Isolation and purification of bacterial plasmids with Qiagen spin Miniprep system &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 6a:&lt;span style=""&gt;        &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;RNA extraction from yeasts&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 6b:&lt;span style=""&gt;        &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;RNA extraction from bacteria&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 7:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;       &lt;/span&gt;Spectrophotometric analysis of DNA in extracted solution &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 8:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;       &lt;/span&gt;Agarose gel electrophoresis of DNA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 9a:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;     &lt;/span&gt;Demonstration of induction/repression mode of &lt;i style=""&gt;lac&lt;/i&gt;-operon regulation system in &lt;i style=""&gt;Escherichia coli&lt;o:p&gt;&lt;/o:p&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 9b:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Determination of level of induction of &lt;i style=""&gt;lac&lt;/i&gt;-operon in &lt;i style=""&gt;Escherichia coli&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 10:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;    &lt;/span&gt;Conjugation in bacteria: Co-culture of MDR &lt;i style=""&gt;Salmonella enteritidis&lt;/i&gt; Typhi with &lt;i style=""&gt;Escherichia coli&lt;/i&gt; HB101 and detection of transconjugants by antibiotic selection method&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 11:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Transformation of &lt;i style=""&gt;Escherichia coli&lt;/i&gt; HB101 by pUC18 or pBR322&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 12:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;      &lt;/span&gt;Study of performance of &lt;i style=""&gt;Hin&lt;/i&gt;dIII and &lt;i style=""&gt;Eco&lt;/i&gt;RI Restriction enzymes stored in lab&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 13a:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;    &lt;/span&gt;Construction of recombinant DNA: Preparation and purification of insert (Lambda DNA fragments) and vector (pUC18) DNA &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;span style=""&gt;                &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 13b:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;  &lt;/span&gt;Construction of recombinant DNA: Ligation of purified insert (Lambda DNA fragments) and vector (pUC18) DNA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 14a:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;    &lt;/span&gt;Amplification of recombinant DNA: Transformation of recombinant pUC18 DNA in &lt;i style=""&gt;Escherichia coli&lt;/i&gt; HB101 &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 14b:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;  &lt;/span&gt;Detection of recombinant DNA: Extraction of recombinant pUC18 DNA from transformed &lt;i style=""&gt;Escherichia coli&lt;/i&gt; HB101 clones &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 14c:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;span style=""&gt;    &lt;/span&gt;Detection of recombinant DNA: Detection of recombinant pUC18 DNA in plasmid extracts of transformed &lt;i style=""&gt;Escherichia coli&lt;/i&gt; HB101 clones by agarose gel electrophoresis &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 103.5pt; text-align: justify; text-indent: -103.5pt;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 15a: &lt;span style=""&gt;   &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Amplification of &lt;i style=""&gt;Escherichia coli&lt;/i&gt; DNA (genes) by Polymerase Chain Reaction (PCR) &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 15b:&lt;span style=""&gt;      &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Randomly Amplified Polymorphic DNA – Polymerase Chain Reaction (RAPD-PCR) &lt;b style=""&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 16: &lt;span style=""&gt;       &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Bacterial plasmid profiling&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Experiment 17: &lt;span style=""&gt;       &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Construction of simple restriction map of plasmid DNA &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: center; text-indent: -1.5in;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: center; text-indent: -1.5in;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ANNEXES&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: center; text-indent: -1.5in;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex I: &lt;span style=""&gt;                    &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Molecular Biology components &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex IIa:&lt;span style=""&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Preparation of buffers&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex IIb:&lt;span style=""&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Tri buffers &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex III:&lt;span style=""&gt;                  &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Phenol &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex IV: &lt;span style=""&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Bacterial nucleoid staining&lt;b style=""&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex V:&lt;span style=""&gt;                    &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Antibiotic susceptibility testing (AST) of bacteria &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex VI:&lt;span style=""&gt;                  &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Broth dilution method to determine Minimum inhibitory concentration (MIC) &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;"  lang="EN-GB"&gt;Annes VII: &lt;span style=""&gt;                &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  lang="EN-GB" &gt;Generation of actinomycete mutants using sodium azide and their analysis&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;"  lang="EN-GB"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex VIII: &lt;span style=""&gt;              &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Replica plating&lt;b style=""&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex IX:&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;span style=""&gt;               &lt;/span&gt;Ames test &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex X:&lt;span style=""&gt;                   &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Determination of ciprofloxacin related mutation rate in wild type &lt;i style=""&gt;Salmonella typhi&lt;o:p&gt;&lt;/o:p&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XI:&lt;span style=""&gt;                  &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;1 Kb ladder DNA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIIa:&lt;span style=""&gt;               &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;i style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Escherichia coli&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; host strains for transformation &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIIb:&lt;span style=""&gt;               &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Alpha-Complementation &lt;b style=""&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIIIa: &lt;span style=""&gt;            &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Construction of simple restriction map of pBR322 using &lt;i style=""&gt;Pst&lt;/i&gt;I, &lt;i style=""&gt;Hin&lt;/i&gt;dIII and &lt;i style=""&gt;Eco&lt;/i&gt;RI &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIIIb: &lt;span style=""&gt;            &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;pUC vectors&lt;b style=""&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIIIc: &lt;span style=""&gt;            &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;pBR322 vector&lt;b style=""&gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XIV:&lt;span style=""&gt;                &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Star activity of Restriction enzymes &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XV: &lt;span style=""&gt;                &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;PCR calculations &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XVI: &lt;span style=""&gt;               &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Southern Blotting &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-align: justify; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XVII: &lt;span style=""&gt;             &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Ethidium bromide &lt;b style=""&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Annex XVIII: &lt;span style=""&gt;            &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Molarity of HCl &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-left: 1.5in; text-indent: -1.5in;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Bibliography:&lt;span style=""&gt;            &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Bibliography &lt;b style=""&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: center;" align="center"&gt;&lt;span style="font-size:100%;"&gt;&lt;b style=""&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal"&gt;&lt;span style="font-size:100%;"&gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;input id="gwProxy" type="hidden"&gt;&lt;!--Session data--&gt;&lt;input onclick="if(typeof(jsCall)=='function'){jsCall();}else{setTimeout('jsCall()',500);}" id="jsProxy" type="hidden"&gt;&lt;div id="refHTML"&gt;&lt;/div&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2472431863178814657-1828617012302524899?l=kiranbabutiwari.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1828617012302524899'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2472431863178814657/posts/default/1828617012302524899'/><link rel='alternate' type='text/html' href='http://kiranbabutiwari.blogspot.com/2010/08/contents-of-my-book-about-to-publish_09.html' title='Contents of my book'/><author><name>Kiran Babu Tiwari</name><uri>http://www.blogger.com/profile/09433876584699149458</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='http://4.bp.blogspot.com/-PQEe9nCaUTM/TiV3SRbn8oI/AAAAAAAAAQ0/N7nr2M9M-as/s220/Kiran%2BBabu.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2472431863178814657.post-1530785393605566972</id><published>2010-05-10T07:44:00.001+05:30</published><updated>2010-05-10T07:47:30.129+05:30</updated><title type='text'>Beta-lactamase (from Wikipedia)</title><content type='html'>&lt;meta equiv="Content-Type" content="text/html; charset=utf-8"&gt;&lt;meta name="ProgId" content="Word.Document"&gt;&lt;meta name="Generator" content="Microsoft Word 12"&gt;&lt;meta name="Originator" content="Microsoft Word 12"&gt;&lt;link rel="File-List" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_filelist.xml"&gt;&lt;link rel="themeData" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_themedata.thmx"&gt;&lt;link rel="colorSchemeMapping" href="file:///C:%5CDOCUME%7E1%5CKIRANB%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtmlclip1%5C01%5Cclip_colorschememapping.xml"&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:worddocument&gt;   &lt;w:view&gt;Normal&lt;/w:View&gt;   &lt;w:zoom&gt;0&lt;/w:Zoom&gt;   &lt;w:trackmoves/&gt;   &lt;w:trackformatting/&gt;   &lt;w:punctuationkerning/&gt;   &lt;w:validateagainstschemas/&gt;   &lt;w:saveifxmlinvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;   &lt;w:ignoremixedcontent&gt;false&lt;/w:IgnoreMixedContent&gt;   &lt;w:alwaysshowplaceholdertext&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;   &lt;w:donotpromoteqf/&gt;   &lt;w:lidthemeother&gt;EN-US&lt;/w:LidThemeOther&gt;   &lt;w:lidthemeasian&gt;X-NONE&lt;/w:LidThemeAsian&gt;   &lt;w:lidthemecomplexscript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;   &lt;w:compatibility&gt;    &lt;w:breakwrappedtables/&gt;    &lt;w:snaptogridincell/&gt;    &lt;w:wraptextwithpunct/&gt;    &lt;w:useasianbreakrules/&gt;    &lt;w:dontgrowautofit/&gt;    &lt;w:splitpgbreakandparamark/&gt;    &lt;w:dontvertaligncellwithsp/&gt;    &lt;w:dontbreakconstrainedforcedtables/&gt;    &lt;w:dontvertalignintxbx/&gt;    &lt;w:word11kerningpairs/&gt;    &lt;w:cachedcolbalance/&gt;   &lt;/w:Compatibility&gt;   &lt;m:mathpr&gt;    &lt;m:mathfont val="Cambria Math"&gt;    &lt;m:brkbin val="before"&gt;    &lt;m:brkbinsub val="&amp;#45;-"&gt;    &lt;m:smallfrac val="off"&gt;    &lt;m:dispdef/&gt;    &lt;m:lmargin val="0"&gt;    &lt;m:rmargin val="0"&gt;    &lt;m:defjc val="centerGroup"&gt;    &lt;m:wrapindent val="1440"&gt;    &lt;m:intlim val="subSup"&gt;    &lt;m:narylim val="undOvr"&gt;   &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;  &lt;w:latentstyles deflockedstate="false" defunhidewhenused="true" defsemihidden="true" defqformat="false" defpriority="99" latentstylecount="267"&gt;   &lt;w:lsdexception locked="false" priority="0" semihidden="false" unhidewhenused="false" qformat="true" name="Normal"&gt;   &lt;w:lsdexception locked="false" priority="9" semihidden="false" unhidewhenused="false" qformat="true" name="heading 1"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 2"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 3"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 4"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 5"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 6"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 7"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 8"&gt;   &lt;w:lsdexception locked="false" priority="9" qformat="true" name="heading 9"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 1"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 2"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 3"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 4"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 5"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 6"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 7"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 8"&gt;   &lt;w:lsdexception locked="false" priority="39" name="toc 9"&gt;   &lt;w:lsdexception locked="false" priority="35" qformat="true" name="caption"&gt;   &lt;w:lsdexception locked="false" priority="10" semihidden="false" unhidewhenused="false" qformat="true" name="Title"&gt;   &lt;w:lsdexception locked="false" priority="1" name="Default Paragraph Font"&gt;   &lt;w:lsdexception locked="false" priority="11" semihidden="false" unhidewhenused="false" qformat="true" name="Subtitle"&gt;   &lt;w:lsdexception locked="false" priority="22" semihidden="false" unhidewhenused="false" qformat="true" name="Strong"&gt;   &lt;w:lsdexception locked="false" priority="20" semihidden="false" unhidewhenused="false" qformat="true" name="Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="59" semihidden="false" unhidewhenused="false" name="Table Grid"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Placeholder Text"&gt;   &lt;w:lsdexception locked="false" priority="1" semihidden="false" unhidewhenused="false" qformat="true" name="No Spacing"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" unhidewhenused="false" name="Revision"&gt;   &lt;w:lsdexception locked="false" priority="34" semihidden="false" unhidewhenused="false" qformat="true" name="List Paragraph"&gt;   &lt;w:lsdexception locked="false" priority="29" semihidden="false" unhidewhenused="false" qformat="true" name="Quote"&gt;   &lt;w:lsdexception locked="false" priority="30" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Quote"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 1"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 2"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 3"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 4"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 5"&gt;   &lt;w:lsdexception locked="false" priority="60" semihidden="false" unhidewhenused="false" name="Light Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="61" semihidden="false" unhidewhenused="false" name="Light List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="62" semihidden="false" unhidewhenused="false" name="Light Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="63" semihidden="false" unhidewhenused="false" name="Medium Shading 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="64" semihidden="false" unhidewhenused="false" name="Medium Shading 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="65" semihidden="false" unhidewhenused="false" name="Medium List 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="66" semihidden="false" unhidewhenused="false" name="Medium List 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="67" semihidden="false" unhidewhenused="false" name="Medium Grid 1 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="68" semihidden="false" unhidewhenused="false" name="Medium Grid 2 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="69" semihidden="false" unhidewhenused="false" name="Medium Grid 3 Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="70" semihidden="false" unhidewhenused="false" name="Dark List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="71" semihidden="false" unhidewhenused="false" name="Colorful Shading Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="72" semihidden="false" unhidewhenused="false" name="Colorful List Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="73" semihidden="false" unhidewhenused="false" name="Colorful Grid Accent 6"&gt;   &lt;w:lsdexception locked="false" priority="19" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="21" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Emphasis"&gt;   &lt;w:lsdexception locked="false" priority="31" semihidden="false" unhidewhenused="false" qformat="true" name="Subtle Reference"&gt;   &lt;w:lsdexception locked="false" priority="32" semihidden="false" unhidewhenused="false" qformat="true" name="Intense Reference"&gt;   &lt;w:lsdexception locked="false" priority="33" semihidden="false" unhidewhenused="false" qformat="true" name="Book Title"&gt;   &lt;w:lsdexception locked="false" priority="37" name="Bibliography"&gt;   &lt;w:lsdexception locked="false" priority="39" qformat="true" name="TOC Heading"&gt;  &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;style&gt; &lt;!--  /* Font Definitions */  @font-face 	{font-family:Wingdings; 	panose-1:5 0 0 0 0 0 0 0 0 0; 	mso-font-charset:2; 	mso-generic-font-family:auto; 	mso-font-pitch:variable; 	mso-font-signature:0 268435456 0 0 -2147483648 0;} @font-face 	{font-family:"Cambria Math"; 	panose-1:2 4 5 3 5 4 6 3 2 4; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;} @font-face 	{font-family:Tahoma; 	panose-1:2 11 6 4 3 5 4 4 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:1627400839 -2147483648 8 0 66047 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:""; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} h1 	{mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-link:"Heading 1 Char"; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	mso-outline-level:1; 	font-size:24.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	font-weight:bold;} h2 	{mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-link:"Heading 2 Char"; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	mso-outline-level:2; 	font-size:18.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	font-weight:bold;} h3 	{mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-link:"Heading 3 Char"; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	mso-outline-level:3; 	font-size:13.5pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	font-weight:bold;} h4 	{mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-link:"Heading 4 Char"; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	mso-outline-level:4; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	font-weight:bold;} h5 	{mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-link:"Heading 5 Char"; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	mso-outline-level:5; 	font-size:10.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman"; 	font-weight:bold;} a:link, span.MsoHyperlink 	{mso-style-noshow:yes; 	mso-style-priority:99; 	color:blue; 	text-decoration:underline; 	text-underline:single;} a:visited, span.MsoHyperlinkFollowed 	{mso-style-noshow:yes; 	mso-style-priority:99; 	color:purple; 	text-decoration:underline; 	text-underline:single;} p 	{mso-style-noshow:yes; 	mso-style-priority:99; 	mso-margin-top-alt:auto; 	margin-right:0in; 	mso-margin-bottom-alt:auto; 	margin-left:0in; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-fareast-font-family:"Times New Roman";} p.MsoAcetate, li.MsoAcetate, div.MsoAcetate 	{mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-link:"Balloon Text Char"; 	margin:0in; 	margin-bottom:.0001pt; 	mso-pagination:widow-orphan; 	font-size:8.0pt; 	font-family:"Tahoma","sans-serif"; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin;} span.Heading1Char 	{mso-style-name:"Heading 1 Char"; 	mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Heading 1"; 	mso-ansi-font-size:24.0pt; 	mso-bidi-font-size:24.0pt; 	font-family:"Times New Roman","serif"; 	mso-ascii-font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman"; 	mso-hansi-font-family:"Times New Roman"; 	mso-bidi-font-family:"Times New Roman"; 	mso-font-kerning:18.0pt; 	font-weight:bold;} span.Heading2Char 	{mso-style-name:"Heading 2 Char"; 	mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Heading 2"; 	mso-ansi-font-size:18.0pt; 	mso-bidi-font-size:18.0pt; 	font-family:"Times New Roman","serif"; 	mso-ascii-font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman"; 	mso-hansi-font-family:"Times New Roman"; 	mso-bidi-font-family:"Times New Roman"; 	font-weight:bold;} span.Heading3Char 	{mso-style-name:"Heading 3 Char"; 	mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Heading 3"; 	mso-ansi-font-size:13.5pt; 	mso-bidi-font-size:13.5pt; 	font-family:"Times New Roman","serif"; 	mso-ascii-font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman"; 	mso-hansi-font-family:"Times New Roman"; 	mso-bidi-font-family:"Times New Roman"; 	font-weight:bold;} span.Heading4Char 	{mso-style-name:"Heading 4 Char"; 	mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Heading 4"; 	mso-ansi-font-size:12.0pt; 	mso-bidi-font-size:12.0pt; 	font-family:"Times New Roman","serif"; 	mso-ascii-font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman"; 	mso-hansi-font-family:"Times New Roman"; 	mso-bidi-font-family:"Times New Roman"; 	font-weight:bold;} span.Heading5Char 	{mso-style-name:"Heading 5 Char"; 	mso-style-priority:9; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Heading 5"; 	mso-ansi-font-size:10.0pt; 	mso-bidi-font-size:10.0pt; 	font-family:"Times New Roman","serif"; 	mso-ascii-font-family:"Times New Roman"; 	mso-fareast-font-family:"Times New Roman"; 	mso-hansi-font-family:"Times New Roman"; 	mso-bidi-font-family:"Times New Roman"; 	font-weight:bold;} span.toctoggle 	{mso-style-name:toctoggle; 	mso-style-unhide:no;} span.tocnumber 	{mso-style-name:tocnumber; 	mso-style-unhide:no;} span.toctext 	{mso-style-name:toctext; 	mso-style-unhide:no;} span.editsection 	{mso-style-name:editsection; 	mso-style-unhide:no;} span.mw-headline 	{mso-style-name:mw-headline; 	mso-style-unhide:no;} span.citation 	{mso-style-name:citation; 	mso-style-unhide:no;} span.z3988 	{mso-style-name:z3988; 	mso-style-unhide:no;} span.printonly 	{mso-style-name:printonly; 	mso-style-unhide:no;} span.reference-accessdate 	{mso-style-name:reference-accessdate; 	mso-style-unhide:no;} span.BalloonTextChar 	{mso-style-name:"Balloon Text Char"; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-unhide:no; 	mso-style-locked:yes; 	mso-style-link:"Balloon Text"; 	mso-ansi-font-size:8.0pt; 	mso-bidi-font-size:8.0pt; 	font-family:"Tahoma","sans-serif"; 	mso-ascii-font-family:Tahoma; 	mso-hansi-font-family:Tahoma; 	mso-bidi-font-family:Tahoma;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin; 	mso-bidi-font-family:"Times New Roman"; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt; 	line-height:115%;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.0in 1.0in 1.0in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;}  /* List Definitions */  @list l0 	{mso-list-id:176777449; 	mso-list-template-ids:164285606;} @list l0:level1 	{mso-level-number-format:bullet; 	mso-level-text:; 	mso-level-tab-stop:.5in; 	mso-level-number-position:left; 	text-indent:-.25in; 	mso-ansi-font-size:10.0pt; 	font-family:Symbol;} @list l1 	{mso-list-id:501972111; 	mso-list-template-ids:528777550;} @list l1:level1 	{mso-level-number-format:bullet; 	mso-level-text:; 	mso-level-tab-stop:.5in; 	mso-level-number-position:left; 	text-indent:-.25in; 	mso-ansi-font-size:10.0pt; 	font-family:Symbol;} @list l1:level2 	{mso-level-number-format:bullet; 	mso-level-text:o; 	mso-level-tab-stop:1.0in; 	mso-level-number-position:left; 	text-indent:-.25in; 	mso-ansi-font-size:10.0pt; 	font-family:"Courier New"; 	mso-bidi-font-family:"Times New Roman";} @list l1:level3 	{mso-level-number-format:bullet; 	mso-level-text:; 	mso-level-tab-stop:1.5in; 	mso-level-number-position:left; 	text-indent:-.25in; 	mso-ansi-font-size:10.0pt; 	font-family:Wingdings;} @list l2 	{mso-list-id:1339426638; 	mso-list-template-ids:-186975206;} ol 	{margin-bottom:0in;} ul 	{margin-bottom:0in;} --&gt; &lt;/style&gt;&lt;!--[if gte mso 10]&gt; &lt;style&gt;  /* Style Definitions */  table.MsoNormalTable 	{mso-style-name:"Table Normal"; 	mso-tstyle-rowband-size:0; 	mso-tstyle-colband-size:0; 	mso-style-noshow:yes; 	mso-style-priority:99; 	mso-style-qformat:yes; 	mso-style-parent:""; 	mso-padding-alt:0in 5.4pt 0in 5.4pt; 	mso-para-margin-top:0in; 	mso-para-margin-right:0in; 	mso-para-margin-bottom:10.0pt; 	mso-para-margin-left:0in; 	line-height:115%; 	mso-pagination:widow-orphan; 	font-size:11.0pt; 	font-family:"Calibri","sans-serif"; 	mso-ascii-font-family:Calibri; 	mso-ascii-theme-font:minor-latin; 	mso-hansi-font-family:Calibri; 	mso-hansi-theme-font:minor-latin;} &lt;/style&gt; &lt;![endif]--&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Beta-lactamase&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt; &lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Beta-lactamases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; are &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enzyme" title="Enzyme"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;enzymes&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; (&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/EC_number" title="EC number"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;EC&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.expasy.org/cgi-bin/nicezyme.pl?3.5.2.6"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.5.2.6&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;) produced by some bacteria and are responsible for their &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Antibiotic_resistance" title="Antibiotic resistance"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;resistance&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactam_antibiotic" title="Beta-lactam antibiotic"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;beta-lactam antibiotics&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; like &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Penicillin" title="Penicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;penicillins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephalosporin" title="Cephalosporin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephalosporins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; (are relatively resistant to beta-lactamase), &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephamycin" title="Cephamycin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephamycins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbapenem" title="Carbapenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbapenems&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; (&lt;a href="http://en.wikipedia.org/wiki/Ertapenem" title="Ertapenem"&gt;ertapenem&lt;/a&gt;). These &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Antibiotic" title="Antibiotic"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;antibiotics&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; have a common element in their molecular structure: a four-atom ring known as a &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactam" title="Beta-lactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;beta-lactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. The lactamase enzyme breaks that ring open, deactivating the molecule's antibacterial properties.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Beta-lactam antibiotics are typically used to treat a broad spectrum of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Gram-positive" title="Gram-positive"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;gram-positive&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Gram-negative" title="Gram-negative"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;gram-negative&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; bacteria. Beta-lactamases produced by gram-negative organisms are usually secreted.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Beta-lactamase may be clinically beneficial when orally administered to preserve the natural &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Intestinal_flora" title="Intestinal  flora"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;intestinal flora&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; during the &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Route_of_administration" title="Route  of administration"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;parenteral administration&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; of antibiotics. "This could provide protection against a broad range of nosocomial pathogens," per Dr. Usha Stiefel at the 47th annual Interscience Conference of Antimicrobial Agents and Chemotherapy.&lt;a href="http://www.medicalimagingmag.com/reuters_article.asp?id=20070920drgd004.html"&gt;[1]&lt;/a&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The structure of a &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Streptomyces" title="Streptomyces"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Streptomyces&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; β lactamase is given by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/GetPage.pl?pdbcode=1BSG"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;1BSG&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;table class="MsoNormalTable" style="" border="0" cellpadding="0"&gt;  &lt;tbody&gt;&lt;tr style=""&gt;   &lt;td style="padding: 0.75pt;"&gt;   &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Contents&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;   &lt;ul type="disc"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Penicillinase"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;1 Penicillinase&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Classification_of_Beta_Lactamase"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2 Classification of Beta        Lactamase&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="circle"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Functional_Classification.5B2.5D"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.1 Functional         Classification&lt;sup&gt;[2]&lt;/sup&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;         &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="square"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Group_1"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.1.1 Group 1&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Group_2"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.1.2 Group 2&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Group_3"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.1.3 Group 3&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Group_4"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.1.4 Group 4&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Molecular_Classification"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2.2 Molecular Classification&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Resistance_in_gram-negative_bacteria"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3 Resistance in gram-negative        bacteria&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="circle"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Extended-spectrum_beta-lactamase_.28ESBL.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1 Extended-spectrum         beta-lactamase (ESBL)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;         &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="square"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Types"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.1 Types&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#TEM_beta-lactamases_.28class_A.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.2 TEM beta-lactamases          (class A)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#SHV_beta-lactamases_.28class_A.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.3 SHV beta-lactamases          (class A)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#CTX-M_beta-lactamases_.28class_A.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.4 CTX-M beta-lactamases          (class A)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#OXA_beta-lactamases_.28class_D.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.5 OXA beta-lactamases          (class D)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Others"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.6 Others&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Treatment"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.1.7 Treatment&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Inhibitor-resistant_.CE.B2-lactamases"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.2 Inhibitor-resistant         β-lactamases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#AmpC-type_.CE.B2-lactamases_.28Class_C.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.3 AmpC-type β-lactamases         (Class C)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Carbapenemases"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4 Carbapenemases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="square"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#IMP-type_carbapenemases_.28one_of_the_metallo-b-lactamases.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.1 IMP-type          carbapenemases (one of the metallo-b-lactamases)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#VIM_.28Verona_integron-encoded_metallo-b-lactamase.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.2 VIM (Verona          integron-encoded metallo-b-lactamase)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#OXA_.28oxacillinase.29_group_of_.CE.B2-lactamases_.28Class_D.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.3 OXA (oxacillinase)          group of β-lactamases (Class D)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#KPC_.28K._pneumoniae_carbapenemase.29_.28Class_A.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.4 KPC (K. pneumoniae          carbapenemase) (Class A)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#CMY_.28Class_C.29"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.5 CMY (Class C)&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#SME.2C_IMI.2C_NMC_and_CcrA"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;3.4.6 SME, IMI, NMC and          CcrA&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Treatment_of_ESBL.2FAmpC.2Fcarbapenemases"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4 Treatment of ESBL/AmpC/carbapenemases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="circle"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#General_Overview"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.1 General Overview&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#According_to_genes"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.2 According to genes&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="square"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#ESBLs"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.2.1 ESBLs&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Inhibitor-Resistant_.CE.B2-Lactamases_2"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.2.2 Inhibitor-Resistant          β-Lactamases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#AmpC"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.2.3 AmpC&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Carbapenemases_2"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.2.4 Carbapenemases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#According_to_Species"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.3 According to Species&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;ul type="square"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Escherichia_coli_or_Klebsiella"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.3.1 Escherichia coli or          Klebsiella&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#Pseudomonas_aeruginosa"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;4.3.2 Pseudomonas          aeruginosa&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/ul&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#See_also"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;5 See also&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#References"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;6 References&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#External_links"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;7 External links&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;/ul&gt;   &lt;/td&gt;  &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Penicillinase&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Penicillinase is a specific type of β-lactamase, showing specificity for &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Penicillin" title="Penicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;penicillins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, again by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Hydrolysis" title="Hydrolysis"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;hydrolysing&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; the &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactam" title="Beta-lactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;beta-lactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; ring. Molecular weights of the various penicillinases tend to cluster near 50kD.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Penicillinase was the first β-lactamase to be identified: it was first isolated by Abraham and Chain in 1940 from gram-negative &lt;i&gt;E. coli&lt;/i&gt; even before penicillin entered clinical use&lt;sup&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-0"&gt;[1]&lt;/a&gt;&lt;/sup&gt; but penicillinase production quickly spread to bacteria that previously did not produce it or only produced it rarely. Penicillinase-resistant beta-lactams such as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Methicillin" title="Methicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;methicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; were developed, but there is now widespread &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Antibiotic_resistance" title="Antibiotic resistance"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;resistance&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; to even these.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Classification of Beta Lactamase&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Functional Classification&lt;sup&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-1"&gt;[2]&lt;/a&gt;&lt;/sup&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Group 1&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CEPHALOSPORINASE, Molecular Class C &lt;i&gt;(not inhibited by clavulanic acid)&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Group 1 are cephalosporinases not inhibited by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic  acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, belonging to the molecular class C&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Group 2&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Group 2 are penicillinases, cephalosporinases, or both inhibited by clavulanic acid, corresponding to the molecular classes A and D reflecting the original TEM and SHV genes. However, because of the increasing number of TEM- and SHV-derived {beta}-lactamases, they were divided into two subclasses, 2a and 2b.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2a&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;PENICILLINASE, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The &lt;i&gt;2a subgroup&lt;/i&gt; contains just penicillinases.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2b&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;BROAD SPECTRUM, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;2b&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; Opposite to 2a , 2b are broad-spectrum {beta}-lactamases, meaning that they are capable of inactivating &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Penicillins" title="Penicillins"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;penicillins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephalosporins" title="Cephalosporins"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephalosporins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; at the same rate. Furthermore, new subgroups were segregated from subgroup 2b:&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2be&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;EXTENDED SPECTRUM, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Subgroup 2be&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, with the letter "e" for extended spectrum of activity, represents the ESBLs, which are capable of inactivating third-generation cephalosporins (&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;ceftazidime&lt;/a&gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefpodoxime" title="Cefpodoxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefpodoxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;) as well as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Monobactams" title="Monobactams"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;monobactams&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; (aztreonam)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2br&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;INHIBITOR RESISTANT, Molecular Class A &lt;i&gt;(diminished inhibition by clavulanic acid)&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The &lt;i&gt;2br&lt;/i&gt; enzymes, with the letter "r" denoting reduced binding to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulbactam" title="Sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, are also called inhibitor-resistant TEM-derivative enzymes; nevertheless, they are commonly still susceptible to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Tazobactam" title="Tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, except where an amino acid replacement exists at position met69.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2c&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CARBENICILLINASE, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Later&lt;i&gt;subgroup 2c&lt;/i&gt; was segregated from group 2 because these enzymes inactivate &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbenicillin" title="Carbenicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbenicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; more than &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Benzylpenicillin" title="Benzylpenicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;benzylpenicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, with some effect on &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cloxacillin" title="Cloxacillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cloxacillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;.yht&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2d&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CLOXACILANASE, Molecular Class D or A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Subgroup 2d&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; enzymes inactivate &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cloxacillin" title="Cloxacillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cloxacillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; more than &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Benzylpenicillin" title="Benzylpenicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;benzylpenicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, with some activity against &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbenicillin" title="Carbenicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbenicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;; these enzymes are poorly inhibited by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and some of them are ESBLs&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;the correct term is "OXACILLINASE". These enzymes are able to inactivate the oxazolylpenicillins like oxacilli, cloxacilli, dicloxacillin. The enzymes belong to the molecular class D not molecular class A.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2e&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CEPHALOSPORINASE, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Subgroup 2e&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; enzymes are cephalosporinases that can also hydrolyse &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Monobactams" title="Monobactams"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;monobactams&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and they are inhibited by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic  acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;GROUP 2f&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CARBAPENAMASE, Molecular Class A&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Subgroup 2f&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; was added because these are &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Serine" title="Serine"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;serine&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-based carbapenemases, in contrast to the zinc-based carbapenemases included in group 3&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Group 3&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;METALLOENZYME, Molecular Class B &lt;i&gt;(not inhibited by clavulanic acid)&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Group 3 are the &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Zinc" title="Zinc"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;zinc&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; based or metallo {beta}-lactamases, corresponding to the molecular class B, which are the only enzymes acting by the metal ion zinc, as discussed above. Metallo B-lactamases are able to hydrolyse penicillins, cephalosporins, and carbapenems. Thus, carbapenems are inhibited by both group 2f (serine-based mechanism) and group 3 (zinc-based mechanism)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Group 4&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;PENICILLINASE, No Molecular Class &lt;i&gt;(not inhibited by clavulanic acid)&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Group 4 are penicillinases that are not inhibited by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic  acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and they do not yet have a corresponding molecular class.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Molecular Classification&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The molecular classification of β-lactamases is based on the nucleotide and amino acid sequences in these enzymes. To date, four classes are recognised (A-D), correlating with the functional classification. Classes A, C, and D act by a &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Serine" title="Serine"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;serine&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-based mechanism, whereas class B or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Metallo-beta-lactamase_protein_fold" title="Metallo-beta-lactamase protein fold"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;metallo-β-lactamases&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; need &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Zinc" title="Zinc"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;zinc&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; for their action&lt;sup&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-2"&gt;[3]&lt;/a&gt;&lt;/sup&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;"Penicillinase" was discovered in 1940 and re-named Beta-lactamase when the structure of the Beta-lactam ring was finally elucidated.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Resistance in gram-negative bacteria&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Among gram-negative bacteria, the emergence of resistance to expanded-spectrum cephalosporins has been a major concern. It appeared initially in a limited number of bacterial species (&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/w/index.php?title=E._cloacae&amp;amp;action=edit&amp;amp;redlink=1" title="E. cloacae (page does not exist)"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. cloacae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; , &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/w/index.php?title=C._freundii&amp;amp;action=edit&amp;amp;redlink=1" title="C. freundii (page does not exist)"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;C. freundii&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/S._marcescens" title="S.  marcescens"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;S. marcescens&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/P._aeruginosa" title="P. aeruginosa"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;P. aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; ) that could mutate to hyperproduce their chromosomal class C β-lactamase. A few years later, resistance appeared in bacterial species not naturally-producing AmpC enzymes (&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Salmonella" title="Salmonella"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Salmonella&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; spp., &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/P._mirabilis" title="P.  mirabilis"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;P. mirabilis&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;) due to the production of TEM- or SHV-type ESBLs. Characteristically, such resistance has included oxyimino- (for example &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftizoxime" title="Ceftizoxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftizoxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; , &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftriaxone" title="Ceftriaxone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftriaxone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftazidime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, as well as the oxyimino-monobactam &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aztreonam" title="Aztreonam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aztreonam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;), but not 7-alpha-methoxy-cephalosporins (&lt;a href="http://en.wikipedia.org/wiki/Cephamycins" title="Cephamycins"&gt;cephamycins&lt;/a&gt;); in other words, (&lt;a href="http://en.wikipedia.org/wiki/Cefoxitin" title="Cefoxitin"&gt;cefoxitin&lt;/a&gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotetan" title="Cefotetan"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotetan&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;) have been blocked by inhibitors such as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanate&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulbactam" title="Sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Tazobactam" title="Tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and did not involve &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbapenems" title="Carbapenems"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbapenems&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Plasmid-mediated AmpC β-lactamases represent a new threat, since they confer resistance to 7-alpha-methoxy-cephalosporins (&lt;a href="http://en.wikipedia.org/wiki/Cephamycins" title="Cephamycins"&gt;cephamycins&lt;/a&gt;) such as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefoxitin" title="Cefoxitin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefoxitin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotetan" title="Cefotetan"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotetan&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; are not affected by commercially-available β-lactamase inhibitors, and can, in strains with loss of outer membrane porins, provide resistance to carbapenems.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-3"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[4]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Extended-spectrum beta-lactamase (ESBL)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Members of the family &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enterobacteriaceae" title="Enterobacteriaceae"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Enterobacteriaceae&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; commonly express plasmid-encoded β-lactamases (e.g., TEM-1, TEM-2, and SHV-1). which confer resistance to penicillins but not to expanded-spectrum cephalosporins. In the mid-1980s a new group of enzymes, the extended-spectrum b-lactamases (ESBLs), was detected. (first detected in Germany in 1983).&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-4"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[5]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; ESBLs are beta-lactamases that hydrolyze extended-spectrum cephalosporins with an oxyimino side chain. These cephalosporins include &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftriaxone" title="Ceftriaxone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftriaxone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftazidime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, as well as the oxyimino-monobactam &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aztreonam" title="Aztreonam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aztreonam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Thus ESBLs confer resistance to these antibiotics and related oxyimino-beta lactams. Typically, they derive from genes for TEM-1, TEM-2, or SHV-1 by mutations that alter the amino acid configuration around the active site of these β-lactamases. This extends the spectrum of β-lactam antibiotics susceptible to hydrolysis by these enzymes. An increasing number of ESBLs not of TEM or SHV lineage have recently been described.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-5"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[6]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; The ESBLs are frequently plasmid encoded. Plasmids responsible for ESBL production frequently carry genes encoding resistance to other drug classes (for example, aminoglycosides). Therefore, antibiotic options in the treatment of ESBL-producing organisms are extremely limited. Carbapenems are the treatment of choice for serious infections due to ESBL-producing organisms, yet carbapenem-resistant isolates have recently been reported. ESBL-producing organisms may appear susceptible to some extended-spectrum cephalosporins. However, treatment with such antibiotics has been associated with high failure rates.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Types&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;TEM beta-lactamases (class A)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;TEM-1 is the most commonly-encountered beta-lactamase in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Gram-negative" title="Gram-negative"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;gram-negative&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; bacteria. Up to 90% of ampicillin resistance in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/E._coli" title="E.  coli"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; is due to the production of TEM-1. Also responsible for the ampicillin and penicillin resistance that is seen in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/H._influenzae" title="H. influenzae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;H. influenzae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/N._gonorrhoeae" title="N.  gonorrhoeae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;N. gonorrhoeae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; in increasing numbers. Although TEM-type beta-lactamases are most often found in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/E._coli" title="E. coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, they are also found in other species of gram-negative bacteria with increasing frequency. The amino acid substitutions responsible for the ESBL phenotype cluster around the active site of the enzyme and change its configuration, allowing access to oxyimino-beta-lactam substrates. Opening the active site to beta-lactam substrates also typically enhances the susceptibility of the enzyme to b-lactamase inhibitors, such as clavulanic acid. Single amino acid substitutions at positions 104, 164, 238, and 240 produce the ESBL phenotype, but ESBLs with the broadest spectrum usually have more than a single amino acid substitution. Based upon different combinations of changes, currently 140 TEM-type enzymes have been described. TEM-10, TEM-12, and TEM-26 are among the most common in the United States.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-6"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[7]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-7"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[8]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-8"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[9]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;SHV beta-lactamases (class A)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;SHV-1 shares 68 percent of its amino acids with TEM-1 and has a similar overall structure. The SHV-1 beta-lactamase is most commonly found in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and is responsible for up to 20% of the plasmid-mediated ampicillin resistance in this species. ESBLs in this family also have amino acid changes around the active site, most commonly at positions 238 or 238 and 240. More than 60 SHV varieties are known. They are the predominant ESBL type in Europe and the United States and are found worldwide. SHV-5 and SHV-12 are among the most common.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-9"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[10]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;CTX-M beta-lactamases (class A)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;These enzymes were named for their greater activity against &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; than other oxyimino-beta-lactam substrates (e.g., &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftazidime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftriaxone" title="Ceftriaxone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftriaxone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefepime" title="Cefepime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefepime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;). Rather than arising by mutation, they represent examples of plasmid acquisition of beta-lactamase genes normally found on the chromosome of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/w/index.php?title=Kluyvera&amp;amp;action=edit&amp;amp;redlink=1" title="Kluyvera (page does not exist)"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Kluyvera&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; species, a group of rarely pathogenic commensal organisms. These enzymes are not very closely related to TEM or SHV beta-lactamases in that they show only approximately 40% identity with these two commonly isolated beta-lactamases. More than 40 CTX-M enzymes are currently known. Despite their name, a few are more active on &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftazidime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; than &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. They have mainly been found in strains of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Salmonella_enterica" title="Salmonella enterica"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Salmonella enterica&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; serovar &lt;i&gt;Typhimurium&lt;/i&gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/E._coli" title="E. coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, but have also been described in other species of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enterobacteriaceae" title="Enterobacteriaceae"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Enterobacteriaceae&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and are the predominant ESBL type in parts of South America. (They are also seen in eastern Europe) CTX-M-14, CTX-M-3, and CTX-M-2 are the most widespread. CTX-M-15 is currently (2006) the most widespread type in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Escherichia_coli" title="Escherichia  coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; the UK and is widely prevalent in the community.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-10"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[11]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;OXA beta-lactamases (class D)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Oxacillin" title="Oxacillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;oxacillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d . The OXA-type beta-lactamases confer resistance to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ampicillin" title="Ampicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ampicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephalothin" title="Cephalothin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephalothin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and are characterized by their high hydrolytic activity against &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Oxacillin" title="Oxacillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;oxacillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cloxacillin" title="Cloxacillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cloxacillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and the fact that they are poorly inhibited by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. While most ESBLs have been found in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/E._coli" title="E. coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and other &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enterobacteriaceae" title="Enterobacteriaceae"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Enterobacteriaceae&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, the OXA-type ESBLs have been found mainly in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/P._aeruginosa" title="P. aeruginosa"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;P. aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. OXA-type ESBLs have been found mainly in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Pseudomonas aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; isolates from Turkey and France. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Others&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Other plasmid-mediated ESBLs, such as PER, VEB, GES, and IBC beta-lactamases, have been described but are uncommon and have been found mainly in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/P._aeruginosa" title="P. aeruginosa"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;P. aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and at a limited number of geographic sites. PER-1 in isolates in Turkey, France, and Italy; VEB-1 and VEB-2 in strains from Southeast Asia; and GES-1, GES-2, and IBC-2 in isolates from South Africa, France, and Greece. PER-1 is also common in multiresistant acinetobacter species in Korea and Turkey. Some of these enzymes are found in Enterobacteriaceae as well, whereas other uncommon ESBLs (such as BES-1, IBC-1, SFO-1, and TLA-1) have been found only in Enterobacteriaceae.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Treatment&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;While ESBL-producing organisms were previously associated with hospitals and institutional care, these organisms are now increasingly found in the community. CTX-M-15-positive &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Escherichia_coli" title="Escherichia  coli"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; are a cause of community-acquired &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cystitis" title="Cystitis"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;urinary infections&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; in the UK,&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-11"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[12]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and tend to be resistant to all oral β-lactam antibiotics, as well as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Quinolones" title="Quinolones"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;quinolones&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulfonamide_%28medicine%29" title="Sulfonamide (medicine)"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulfonamides&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Treatment options may include &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Nitrofurantoin" title="Nitrofurantoin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;nitrofurantoin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Fosfomycin" title="Fosfomycin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;fosfomycin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Mecillinam" title="Mecillinam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;mecillinam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Chloramphenicol" title="Chloramphenicol"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;chloramphenicol&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. In desperation, once-daily &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ertapenem" title="Ertapenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ertapenem&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Gentamicin" title="Gentamicin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;gentamicin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; injections may also be used.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Inhibitor-resistant β-lactamases&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Although the inhibitor-resistant β-lactamases are not ESBLs, they are often discussed with ESBLs because they are also derivatives of the classical TEM- or SHV-type enzymes. These enzymes were at first given the designation IRT for inhibitor-resistant TEM β-lactamase; however, all have subsequently been renamed with numerical TEM designations. There are at least 19 distinct inhibitor-resistant TEM β-lactamases. Inhibitor-resistant TEM β-lactamases have been found mainly in clinical isolates of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/E._coli" title="E.  coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;E. coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, but also some strains of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Klebsiella_oxytoca" title="Klebsiella  oxytoca"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Klebsiella oxytoca&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/P._mirabilis" title="P. mirabilis"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;P. mirabilis&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/w/index.php?title=Citrobacter_freundii&amp;amp;action=edit&amp;amp;redlink=1" title="Citrobacter freundii (page does not exist)"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Citrobacter freundii&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; .Although the inhibitor-resistant TEM variants are resistant to inhibition by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic  acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulbactam" title="Sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, thereby showing clinical resistance to the beta-lactam—lactamase inhibitor combinations of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Amoxicillin" title="Amoxicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;amoxicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;clavulanate&lt;/a&gt; (&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Co-amoxiclav" title="Co-amoxiclav"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Co-amoxiclav&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;), &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ticarcillin" title="Ticarcillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ticarcillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanate&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ampicillin/sulbactam" title="Ampicillin/sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ampicillin/sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, they normally remain susceptible to inhibition by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Tazobactam" title="Tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and subsequently the combination of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Piperacillin/tazobactam" title="Piperacillin/tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;piperacillin/tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, although resistance has been described. To date, these beta-lactamases have primarily been detected in France and a few other locations within Europe..&lt;sup&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-12"&gt;[13]&lt;/a&gt;&lt;/sup&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;AmpC-type β-lactamases (Class C)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;AmpC type β-lactamases are commonly isolated from extended-spectrum cephalosporin-resistant Gram-negative bacteria. AmpC β-lactamases (also termed class C or group 1) are typically encoded on the chromosome of many Gram-negative bacteria including &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Citrobacter" title="Citrobacter"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Citrobacter&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Serratia" title="Serratia"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Serratia&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enterobacter" title="Enterobacter"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Enterobacter&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; species where its expression is usually inducible; it may also occur on &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Escherichia_coli" title="Escherichia  coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Escherichia coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; but is not usually inducible, although it can be hyperexpressed. AmpC type β-lactamases may also be carried on plasmids.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-13"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[14]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; AmpC β-lactamases, in contrast to ESBLs, hydrolyse broad and extended-spectrum cephalosporins (cephamycins as well as to oxyimino-β-lactams) but are not inhibited by β-lactamase inhibitors such as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Carbapenemases&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Carbapenems are famously stable to AmpC β-lactamases and extended-spectrum-β-lactamases. Carbapenemases are a diverse group of b-lactamases that are active not only against the oxyimino-cephalosporins and cephamycins but also against the carbapenems. Aztreonam is stable to the metallo-β-lactamases but many IMP and VIM producers are resistant, owing to other mechanisms. Carbapenemases were formerly believed to derive only from classes A, B, and D, but a class C carbapenemase has been described.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;IMP-type carbapenemases (one of the metallo-b-lactamases)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Plasmid mediated IMP-type carbapenemases, 17 varieties of which are currently known, became established in Japan in the 1990s in both enteric gram-negative organisms and in &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Pseudomonas" title="Pseudomonas"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Pseudomonas&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Acinetobacter" title="Acinetobacter"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Acinetobacter&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; species. IMP enzymes spread slowly to other countries in the Far East, were reported from Europe in 1997, and have been found in Canada and Brazil.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;VIM (Verona integron-encoded metallo-b-lactamase)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;A second growing family of carbapenemases, the VIM family, was reported from Italy in 1999 and now includes 10 members, which have a wide geographic distribution in Europe, South America, and the Far East and have been found in the United States. VIM-1 was discovered in P. aeruginosa in Italy in 1996; subsequently, VIM-2 -now the predominant variant- was found repeatedly in Europe and the Far East; VIM-3 and -4 are minor variants of VIM-2 and -1, respectively. VIM enzymes mostly occur in P. aeruginosa, also P. putidaand, very rarely, Enterobacteriaceae&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Amino acid sequence diversity is up to 10% in the VIM family, 15% in the IMP family, and 70% between VIM and IMP. Enzymes of both the families nevertheless are similar.1 Both are integron-associated, sometimes within plasmids. Both hydrolyse all β-lactams except monobactams, and evade all β-lactam inhibitors.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;OXA (oxacillinase) group of β-lactamases (Class D)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The OXA group of β-lactamases mainly occur in Acinetobacter species and are divided into two clusters. OXA carbapenemases hydrolyse carbapenems very slowly &lt;i&gt;in vitro&lt;/i&gt;, and the high MICs seen for some Acinetobacter hosts (&gt;64 mg/L) may reflect secondary mechanisms. They are sometimes augmented in clinical isolates by additional resistance mechanisms, such as impermeability or efflux. OXA carbapenemases also tend to have a reduced hydrolytic efficiency towards penicillins and cephalosporins.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-14"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[15]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;KPC (K. pneumoniae carbapenemase) (Class A)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;A few class A enzymes, notably the plasmid-mediated KPC enzymes, are effective carbapenemases as well. Three variants are known, distinguished by one or two amino-acid substitutions. KPC-1 was found in North Carolina, KPC-2 in Baltimore and KPC-3 in New York. They have only 45% homology with SME and NMC/IMI enzymes and, unlike them, can be encoded by self-transmissible plasmids.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;CMY (Class C)&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;The first class C carbapenemase was described in 2006 and was isolated from a virulent strain of &lt;i&gt;Enterobacter aerogenes&lt;/i&gt;.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-15"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[16]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; It is carried on a plasmid, pYMG-1, and is therefore transmissible to other bacterial strains.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_note-16"&gt;&lt;sup&gt;&lt;span style=";font-family:&amp;quot;;" &gt;[17]&lt;/span&gt;&lt;/sup&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;SME, IMI, NMC and CcrA&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;generally of little clinical significance.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;CcrA (CfiA). Its gene occurs in c. 1-3% of B. fragilis isolates, but fewer produce the enzyme since expression demands appropriate migration of an insertion sequence. CcrA was known before imipenem was introduced, and producers have shown little subsequent increase.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Treatment of ESBL/AmpC/carbapenemases&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;General Overview&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;In general, an isolate is suspected to be an ESBL producer when it shows &lt;i&gt;in vitro&lt;/i&gt; susceptibility to the second-generation cephalosporins (cefoxitin, cefotetan) but resistance to the third-generation cephalosporins and to aztreonam. Moreover, one should suspect these strains when treatment with these agents for Gram-negative infections fails despite reported &lt;i&gt;in vitro&lt;/i&gt; susceptibility. Once an ESBL-producing strain is detected, the laboratory should report it as "resistant" to all penicillins, cephalosporins, and aztreonam, even if it is tested as susceptible. Associated resistance to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aminoglycosides" title="Aminoglycosides"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aminoglycosides&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Trimethoprim" title="Trimethoprim"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;trimethoprim&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-&lt;a href="http://en.wikipedia.org/wiki/Sulfamethoxazole" title="Sulfamethoxazole"&gt;sulfamethoxazole&lt;/a&gt;, as well as high frequency of co-existence of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Fluoroquinolone" title="Fluoroquinolone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;fluoroquinolone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; resistance, creates problems. Beta-lactamase inhibitors such as &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanate&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulbactam" title="Sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Tazobactam" title="Tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;i&gt;in vitro&lt;/i&gt; inhibit most ESBLs, but the clinical effectiveness of beta-lactam/beta-lactamase inhibitor combinations cannot be relied on consistently for therapy.&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephamycins" title="Cephamycins"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Cephamycins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; (&lt;a href="http://en.wikipedia.org/wiki/Cefoxitin" title="Cefoxitin"&gt;cefoxitin&lt;/a&gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotetan" title="Cefotetan"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotetan&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;) are not hydrolyzed by majority of ESBLs, but are hydrolyzed by associated AmpC-type β-lactamase. Also, β-lactam/β-lactamase inhibitor combinations may not be effective against organisms that produce AmpC-type β-lactamase. Sometimes these strains decrease the expression of outer membrane proteins, rendering them resistant to cephamycins. &lt;i&gt;In vivo&lt;/i&gt; studies have yielded mixed results against ESBL-producing &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. (&lt;a href="http://en.wikipedia.org/wiki/Cefepime" title="Cefepime"&gt;Cefepime&lt;/a&gt;, a fourth-generation cephalosporin, has demonstrated &lt;i&gt;in vitro&lt;/i&gt; stability in the presence of many ESBL/AmpC strains.) Currently, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbapenems" title="Carbapenems"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbapenems&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; are generally regarded as the preferred agent for treatment of infections due to ESBL-producing organisms. Carbapenems are resistant to ESBL-mediated hydrolysis and exhibit excellent &lt;i&gt;in vitro&lt;/i&gt; activity against strains of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Enterobacteriaceae" title="Enterobacteriaceae"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Enterobacteriaceae&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; expressing ESBLs.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;According to genes&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ESBLs&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Strains producing only ESBLs are susceptible to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephamycins" title="Cephamycins"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephamycins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbapenems" title="Carbapenems"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbapenems&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;i&gt;in vitro&lt;/i&gt; and show little if any inoculum effect with these agents.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;For organisms producing &lt;b&gt;TEM&lt;/b&gt; and &lt;b&gt;SHV&lt;/b&gt; type ESBLs, apparent &lt;i&gt;in vitro&lt;/i&gt; sensitivity to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefepime" title="Cefepime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefepime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Piperacillin/tazobactam" title="Piperacillin/tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;piperacillin/tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; is common, but both drugs show an inoculum effect, with diminished susceptibility as the size of the inoculum is increased from 10&lt;sup&gt;5&lt;/sup&gt;to 10&lt;sup&gt;7&lt;/sup&gt;organisms.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Strains with some &lt;b&gt;CTX-M&lt;/b&gt;–type and &lt;b&gt;OXA&lt;/b&gt;-type ESBLs are resistant to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefepime" title="Cefepime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefepime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; on testing, despite the use of a standard inoculum.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Inhibitor-Resistant β-Lactamases&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Although the inhibitor-resistant TEM variants are resistant to inhibition by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanic_acid" title="Clavulanic acid"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanic acid&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Sulbactam" title="Sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, thereby showing clinical resistance to the beta-lactam—lactamase inhibitor combinations of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Amoxicillin" title="Amoxicillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;amoxicillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;clavulanate&lt;/a&gt; (&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Co-amoxiclav" title="Co-amoxiclav"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Co-amoxiclav&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;), &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ticarcillin" title="Ticarcillin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ticarcillin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;-&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Clavulanate" title="Clavulanate"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;clavulanate&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ampicillin/sulbactam" title="Ampicillin/sulbactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ampicillin/sulbactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, they remain susceptible to inhibition by &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Tazobactam" title="Tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and subsequently the combination of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Piperacillin/tazobactam" title="Piperacillin/tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;piperacillin/tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;AmpC&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;AmpC-producing strains are typically resistant to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/w/index.php?title=Oxyimino-beta_lactams&amp;amp;action=edit&amp;amp;redlink=1" title="Oxyimino-beta lactams (page does not exist)"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;oxyimino-beta lactams&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephamycins" title="Cephamycins"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephamycins&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and are susceptible to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Carbapenems" title="Carbapenems"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;carbapenems&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;; however, diminished porin expression can make such a strain carbapenem-resistant as well.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Carbapenemases&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;Strains with &lt;b&gt;IMP-, VIM-, and OXA&lt;/b&gt;-type carbapenemases usually remain susceptible to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aztreonam" title="Aztreonam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aztreonam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Resistance to non–b-lactam antibiotics is common in strains making any of these enzymes, such that alternative options for non–b-lactam therapy need to be determined by direct susceptibility testing. Resistance to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Fluoroquinolones" title="Fluoroquinolones"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;fluoroquinolones&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aminoglycosides" title="Aminoglycosides"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aminoglycosides&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; is especially high.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;According to Species&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Escherichia coli&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt; or &lt;i&gt;Klebsiella&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;For infections caused by ESBL-producing &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Escherichia_coli" title="Escherichia  coli"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Escherichia coli&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Klebsiella" title="Klebsiella"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Klebsiella&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; species, treatment with &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Imipenem" title="Imipenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;imipenem&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Meropenem" title="Meropenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;meropenem&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; has been associated with the best outcomes in terms of survival and bacteriologic clearance. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefepime" title="Cefepime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Cefepime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Piperacillin/tazobactam" title="Piperacillin/tazobactam"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;piperacillin/tazobactam&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; have been less successful. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftriaxone" title="Ceftriaxone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Ceftriaxone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cefotaxime" title="Cefotaxime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cefotaxime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ceftazidime" title="Ceftazidime"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ceftazidime&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; have failed even more often, despite the organism's susceptibility to the antibiotic &lt;i&gt;in vitro&lt;/i&gt;. Several reports have documented failure of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Cephamycin" title="Cephamycin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;cephamycin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; therapy as a result of resistance due to porin loss. Some patients have responded to &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Aminoglycoside" title="Aminoglycoside"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;aminoglycoside&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; or &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Quinolone" title="Quinolone"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;quinolone&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; therapy, but in a recent comparison of &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Ciprofloxacin" title="Ciprofloxacin"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;ciprofloxacin&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; and &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Imipenem" title="Imipenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;imipenem&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; for bacteremia involving an ESBL-producing &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/K._pneumoniae" title="K. pneumoniae"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;K. pneumoniae&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;, &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Imipenem" title="Imipenem"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;imipenem&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; produced the better outcome.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Pseudomonas aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;There have been few clinical studies to define the optimal therapy for infections caused by ESBL producing &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa"&gt;&lt;i&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Pseudomonas aeruginosa&lt;/span&gt;&lt;/i&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; strains.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;  &lt;p class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;References&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;  &lt;ol start="1" type="1"&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-0"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      Abraham EP, Chain E (1940). "An enzyme from bacteria able to destroy      penicillin". &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;46&lt;/b&gt;: 837. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;doi&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;:&lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://dx.doi.org/10.1038%2F146837a0"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;10.1038/146837a0&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;.&lt;span style="display: none;"&gt; &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-1"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Bush K, Jacoby GA, Medeiros AA.1995. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://aac.asm.org/cgi/reprint/39/6/1211?ijkey=c8e8586b43c1d0526d3f78dcfadea52ad10fb65d&amp;amp;keytype2=tf_ipsecsha"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"A functional classification scheme for      beta-lactamases and its correlation with molecular structure."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;i&gt;Antimicrob Agents Chemother.&lt;/i&gt;. 1995;39: 1211-33&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-2"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Ambler RP.1980. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&amp;amp;db=pubmed&amp;amp;list_uids=6109327&amp;amp;dopt=Abstract"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"The structure of beta-lactamases."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;i&gt;Philos Trans R Soc Lond B Biol Sci.&lt;/i&gt;. 1980;289:      321-31&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-3"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Philippon A, Arlet B, Jacoby GA.2002. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://aac.asm.org/cgi/reprint/46/1/1.pdf"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Plasmid-determined      AmpC-type β-lactamases"&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      &lt;i&gt;Antimicrob Agents Chemother.&lt;/i&gt;. 2002; 46: 1-11&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-4"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Knothe H, Shah P. Kremery V, et al. 1983. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.springerlink.com/content/g4r4734xk8148r1u/"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Transferable resistance to cefotaxime, cefoxitin,      cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae      and&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Serratia_marcescens" title="Serratia  marcescens"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;Serratia      marcescens&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;" &lt;i&gt;Infection&lt;/i&gt;. 1983;      11: 315-7&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-5"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Emery, C. L., and L. A. Weymouth. 1997. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://jcm.asm.org/cgi/content/abstract/35/8/2061?ijkey=d2affb0b60c6a70b4b4f1324e5c76e4c2559e370&amp;amp;keytype2=tf_ipsecsha"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Detection and clinical significance of extended-spectrum      β-lactamases in a tertiary-care medical center"&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; &lt;i&gt;J. Clin. Microbiol.&lt;/i&gt;. 35:2061-2067&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-6"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Paterson DL, Hujer KM, Hujer AM, &lt;i&gt;et al.&lt;/i&gt;2003. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://aac.asm.org/cgi/reprint/47/11/3554"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Extended-spectrum      b-lactamases in Klebsiella pneumoniae bloodstream isolates from seven      countries: dominance and widespread prevalence of SHV- and CTX-M-type      b-lactamases."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      Antimicrob Agents Chemother&lt;i&gt;. 2003;&lt;/i&gt; 47:3554-60.&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-7"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Bradford PA.2001. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://intl-cmr.asm.org/cgi/reprint/14/4/933"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Extended-spectrum β-lactamases in the 21st      century:characterization, epidemiology, and detection of this important resistance      threat."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; Clin Microbiol Rev.&lt;i&gt;. 2001;      48:933-51&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-8"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *George A. Jacoby, M.D., and Luisa Silvia Munoz-Price, M.D..2005. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://content.nejm.org/cgi/reprint/352/4/380.pdf?ijkey=e86019f128eb29d6015410037f622e01e12cadec"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"mechanisms of disease: The New      beta-Lactamases."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt; N      Engl J Med.&lt;i&gt;. 2005;352:380-91.&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-9"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      *Paterson DL, Hujer KM, Hujer AM, &lt;i&gt;et al.&lt;/i&gt;2003. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://aac.asm.org/cgi/reprint/47/11/3554"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Extended-spectrum      b-lactamases in Klebsiella pneumoniae bloodstream isolates from seven      countries: dominance and widespread prevalence of SHV- and CTX-M-type      b-lactamases."&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      "Antimicrob Agents Chemother&lt;i&gt;. 2003; 47:3554-60.&lt;/i&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-10"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      Woodford N, Ward E, Kaufmann ME, &lt;i&gt;et al.&lt;/i&gt;. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.hpa.org.uk/cfi/armrl/ARMRL_posters/Woodford%20ECCMID%202004%20poster.pdf"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;"Molecular characterisation of &lt;i&gt;Escherichia coli&lt;/i&gt;      isolates producing CTX-M-15 extended-spectrum β-lactamase (ESBL) in the      United Kingdom"&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;      (PDF). Health Protection Agency. &lt;/span&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://www.hpa.org.uk/cfi/armrl/ARMRL_posters/Woodford%20ECCMID%202004%20poster.pdf"&gt;&lt;span style=";font-family:&amp;quot;;" &gt;http://www.hpa.org.uk/cfi/armrl/ARMRL_posters/Woodford%20ECCMID%202004%20poster.pdf&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=";font-family:&amp;quot;;font-size:100%;"  &gt;. Retrieved 2006-11-19.&lt;span style="display: none;"&gt; &lt;/span&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/li&gt;&lt;li class="MsoNormal" style="text-align: justify; line-height: normal;"&gt;&lt;span style="font-size:100%;"&gt;&lt;a href="http://en.wikipedia.org/wiki/Beta-lactamase#cite_ref-11"&gt;&lt;b&gt;&lt;span style=";font-family:&amp;quot;;" &gt;^&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;spa
